ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0036498;IRE1-mediated unfolded protein response;6.0;1.0;0.8231203125901445;9.628524252492122;55.46397693329154;5.825829909099042;0.0018563293936187412;0.6210535250702663;[ZBTB17, XBP1, WFS1, EDEM1, SYVN1, ARFGAP1, ERN1, EXTL2, CTDSP2, LMNA, DNAJB11, TPP1, HYOU1]
GO:0000188;inactivation of MAPK activity;13.0;0.8436909121759173;0.8844004208555951;9.558319993818873;2610.871803759405;6.518977089658987;0.08738352963975493;0.7959357562962344;[PPP2CA, DUSP22, DUSP5, DUSP14]
GO:0000187;activation of MAPK activity;13.0;0.811012628672052;0.8680612791036626;9.526741558182179;3706.2450018205795;4.759793790865545;0.12404468480698592;0.705971040585548;[ERN1, DUSP5, KARS, PDE6H, TAOK2, RIPK1, CCL19, THBS1, MAPK8IP3]
GO:0000184;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;10.0;0.8933024483968273;0.861892236059334;9.57851383191746;717.2549128915896;4.989581884898423;0.0240058764469685;0.6704084614939124;[UPF2, UPF1, RPS9, SMG1, RPL3, RPS7, EIF4A3, RPL23A, CASC3, SMG5, PPP2CA, RPS15, SKIV2L, ETF1, DCP1A, RPL29, DCP2, RPL19]
GO:0050679;positive regulation of epithelial cell proliferation;6.0;0.7192862368539868;0.682763431017138;8.647694999480395;65.06748660449396;4.584116776790259;0.002177750219716307;0.5575522577384293;[TBX1, SFRP1, XBP1, WDR48, SP1, ITGB3, CCL5, ARNT, ATP7A, NME1]
GO:0051402;neuron apoptotic process;5.0;0.8259837884571596;0.7032329060895001;9.022388448921806;23.44398779513952;6.113511981550823;7.846491732841165E-4;0.6028862989048107;[POLB, PIGT, CDK5, DIABLO, MAX, BID, CIT]
GO:1903892;negative regulation of ATF6-mediated unfolded protein response;9.0;1.0;0.896240625180289;9.628524252492122;384.78934721132015;9.083926447120524;0.012878553163233311;0.8607930461318132;[WFS1]
GO:1900264;positive regulation of DNA-directed DNA polymerase activity;10.0;1.0;0.9152410118609203;9.628524252492122;1106.254199480119;7.9853141584524145;0.03702533249245755;0.8236103492792612;[RFC3, RFC4]
GO:0006974;cellular response to DNA damage stimulus;4.0;0.5696777571895439;0.534838878594772;7.469040003138749;28.997869804256865;3.161008442547652;9.705326059599744E-4;0.4116541187538124;[USP36, FEN1, BTG2, CDKN1A, SMG1, WDR48, DCLRE1C, CCNH, CIB1, MCM10, BRCA1, AATF, YY1, POLB, NIPBL, CHAF1B, CHAF1A, EXO1, CASP2, EP300, CTLA4, TOPBP1, GTSE1, UPF1, AQR, TIPIN, RFC3, RFC4, FBXO18, DTX3L, NCOA6, PARP2, NSMCE2, RAD23A, TFIP11, MASTL, DDB1, NEIL3, RAD51C, TFDP2, MSH3, DDIT4, TIMELESS, PNKP, COPS7A, TANK, RAD51AP1, TFPT, NUAK1, CCNB1, POLR2B, RBBP5, RAD21, RAD54L, POLR2G, USP51, BID, E2F7, E2F8, FANCI, POLQ, UBE2B, EYA2, XRCC5, INTS3, NONO, GINS4, DONSON, APEX2, CNOT10, CDC7, GTF2H4, SETX, CDK9, SMUG1, CNOT4, CNOT6, HIST3H2A, COPS5, RAD51, NPLOC4, CNOT1, UBE2T, POLE2, BCL3, CNOT3, TAOK2, CDK2, MNDA, ERCC5, CNOT8]
GO:1900029;positive regulation of ruffle assembly;9.0;1.0;0.896240625180289;9.628524252492122;200.30665838708023;7.138016298065211;0.006704083591926775;0.7612791106150483;[FAM98A]
GO:1903779;regulation of cardiac conduction;7.0;0.6913464685778243;0.6965925995461126;8.763526815005518;28.828680454715183;5.788089581116195;9.648699906913433E-4;0.6469225356091749;[AHCYL1, NPPA, ITPR2, ATP2A2, CALM3, CALM1, CALM2]
GO:0072334;UDP-galactose transmembrane transport;8.0;0.9326813400603323;0.8413406700301662;9.567899630675686;142.06452249237992;9.083926447120524;0.004754771718050423;0.839552420951524;[SLC35A2, SLC35B1]
GO:0072332;intrinsic apoptotic signaling pathway by p53 class mediator;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;80.0523555558605;5.734022359845919;0.002679280298012042;0.64415753539903;[CDKN1A, ZMAT1, PERP, BCL3, DDIT4, TP53BP2, EP300, KRCC1]
GO:0000070;mitotic sister chromatid segregation;6.0;1.0;0.8231203125901445;9.628524252492122;56.84344269090966;6.311337724880743;0.0019024988710876387;0.6458824173477649;[ESPL1, ZNF207, CDCA8, TUBG1, SMC4, NDC80, ZWINT, MAD2L1]
GO:0035269;protein O-linked mannosylation;9.0;1.0;0.896240625180289;9.628524252492122;364.0992215367897;7.069023426578259;0.012186073276810977;0.757750811958709;[DPM3, SDF2L1]
GO:0042832;defense response to protozoan;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;69.6526388451159;6.832634648514029;0.0023312111388408135;0.6725415662651573;[IL4R, IRF4, BCL3, IL12A, LYST]
GO:0006813;potassium ion transport;7.0;0.7980440201809971;0.7499413753476991;9.310070521373587;34.16983994150393;4.61801832846594;0.001143633791982704;0.587085037334763;[KCNK6, KCND1, SLC9A6, KCNK12, CDK2, PKD2L1, KCNK3]
GO:0000165;MAPK cascade;9.0;0.7436939687323844;0.7680876095464813;9.236482164716097;231.45054935470895;4.069963362931594;0.007746441594931149;0.6043787408332628;[OXTR, YWHAB, IL5RA, RASGRP4, PABPN1, CCL5, CTSH, NCAM1, MBP, RIPK1, PDGFRB, MAP3K3, DUSP5, KSR1, GFRA2, SPTB, NFKB1, SETX, ITPKB, KARS, PTPRA, TNIP2, TAOK2, CCM2, KRAS, CALM1, HBEGF]
GO:0071277;cellular response to calcium ion;6.0;1.0;0.8231203125901445;9.628524252492122;78.50383844342444;5.433268205826786;0.0026274528238337297;0.6009779013089371;[ITPKB, CPNE2, ECT2, ARID1A, RASGRP2, TUBG1]
GO:0071398;cellular response to fatty acid;6.0;0.7369933605727446;0.6916169928765168;9.004369943419128;203.00017448222317;5.8067817141283475;0.006794233151624104;0.6200793994936333;[SFRP1, CCNB1, GNG2, XRCC5, NME1]
GO:0000281;mitotic cytokinesis;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;28.615093046006976;5.649939242635378;9.577214123380678E-4;0.5791791674783379;[PDCD6IP, SPAST, SON, ESPL1, KIF4A, CFL1, JTB, CHMP4B, KIF23, KIF20A, ECT2, CIT]
GO:0071158;positive regulation of cell cycle arrest;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;83.12201169572153;5.395046993006588;0.002782018926502022;0.6268223193749;[ZBTB17, BTG2, CDKN1A, CNOT10, BRCA1, CNOT4, CNOT6, CCNB1, TFDP2, FAP, CNOT1, CNOT3, CDK2, CASP2, EP300, CNOT8, GTSE1, E2F7, E2F8]
GO:2000378;negative regulation of reactive oxygen species metabolic process;6.0;0.7763722522362496;0.7113064387082693;9.253830803050711;113.12708673636307;5.905872616772578;0.003786261785297929;0.6251469128630576;[BCR, TFAP2A, BECN1, CTNS, BRCA1, AATF, SIRT2]
GO:0000056;ribosomal small subunit export from nucleus;13.0;1.0;0.9625549647676366;9.628524252492122;269.30067979732365;7.8311634786251565;0.009013251397939615;0.8630410292508717;[RPS15]
GO:0002224;toll-like receptor signaling pathway;11.0;0.6763753087927167;0.7706166067260205;9.040737587590003;409.6592600291497;5.311165509025885;0.01371092676377766;0.7040422034557006;[COLEC12, NFKBIA, FGA, TNIP2, ITGB2, FGG, RIPK1, PIK3C3, TANK, HAVCR2, HSP90B1]
GO:0051310;metaphase plate congression;6.0;0.8436909121759173;0.7449657686781032;9.34084218004034;45.439948165668724;5.948432231191374;0.0015208341718066008;0.6273234135236593;[BECN1, SEH1L, KIF14, CDCA8, NDC80, RAB11A, CENPE, CENPF, CCNB1, NUP62, CHMP4B, KIF2C, CHMP6, FAM83D, KPNB1]
GO:0070059;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;84.12593595584649;6.343086423195323;0.002815619368015229;0.6753050999230941;[ERN1, XBP1, BBC3]
GO:0035249;synaptic transmission, glutamatergic;8.0;1.0;0.875;9.628524252492122;25.73829654599903;6.444869117505266;8.61437622431563E-4;0.7045909063862833;[ALS2, CDK5, SLC1A4]
GO:0006882;cellular zinc ion homeostasis;10.0;1.0;0.9152410118609203;9.628524252492122;329.3407122754199;6.375876246018314;0.011022737252460356;0.7413036195908642;[MT1G, SLC39A14]
GO:1902513;regulation of organelle transport along microtubule;6.0;0.6997970393407541;0.6730188322605215;8.98189708756707;69.55073361493433;7.57984905034425;0.0023278004624953893;0.710754145523778;[RHOT1, NEFH]
GO:0045048;protein insertion into ER membrane;8.0;0.8259837884571596;0.7879918942285797;9.280217558223907;56.10872226547124;7.9853141584524145;0.0018779084396536687;0.7833693374183408;[TRAM2]
GO:0006887;exocytosis;6.0;0.6696747006330769;0.657957662906683;8.375761283996754;37.082880499217325;3.1596706497059923;0.0012411306378830758;0.4847060165558207;[SERPINA3, PYGB, SIGLEC9, WDR1, ITGB3, ITGB2, ABCA12, RPH3A, TRIM9, HK3, PSMD7, PSMD2, LAMP2, PHACTR2, CTSH, SDF4, FAM3C, GUSB, SNAP29, FGA, ACTR2, SERPINB1, FCER1G, FGG, PLAUR, COMMD3, RNASE3, TMEM173, UNC13D, SYTL3, SERPINB6, ACLY, EXOC3, VAMP4, DOCK2, ALDOA, VAMP5, SLC27A2, KPNB1, EXOC1, CSTB, PDXK, CLEC12A, UBR4, IQGAP2, THBS1, CORO1A, STX11, C3, RAP1B, CLEC3B, CCL5, PSMB1, NCKAP1L, A2M, RAB6A, ARFGEF2, TMEM30A, XRCC5, HSPA6, SURF4, RAB27B, LILRB3, NFKB1, RAB11A, COPS5, SNX19, CDK5, FABP5, IMPDH2, VPS41, RAB18, CD9, PTX3, MNDA, DEGS1, MAN2B1, CALM1]
GO:0006635;fatty acid beta-oxidation;9.0;0.811012628672052;0.801746939516315;9.464221201200845;579.9307786885206;5.734022359845919;0.019409761258888828;0.6894787953221185;[ACOX2, CPT2, HSD17B4, ETFA, ETFB, SLC27A2, HIBCH]
GO:0071332;cellular response to fructose stimulus;8.0;1.0;0.875;9.628524252492122;222.42719610598223;8.16763571524637;0.007444438082186963;0.7926932703116032;[XBP1]
GO:0071333;cellular response to glucose stimulus;8.0;1.0;0.875;9.628524252492122;272.3004295980195;5.69953618377475;0.009113650324169357;0.6664745454937787;[ERN1, XBP1, NME1]
GO:0072540;T-helper 17 cell lineage commitment;8.0;1.0;0.875;9.628524252492122;46.25983793501841;7.9853141584524145;0.0015482751445338478;0.7833693374183408;[IL6, IRF4]
GO:0071578;zinc ion import across plasma membrane;10.0;1.0;0.9152410118609203;9.628524252492122;277.3394324620908;7.8311634786251565;0.009282301215221672;0.8157270763441555;[SLC39A14]
GO:0016572;histone phosphorylation;8.0;0.7090535922965819;0.729526796148291;9.195660170195843;367.80445225036385;6.444869117505266;0.012310084014303157;0.7045909063862833;[RPS6KA4, CCNB1, CDK2]
GO:0072425;signal transduction involved in G2 DNA damage checkpoint;9.0;0.9326813400603323;0.8625812952104552;9.590783924509275;196.6208089386036;7.292166977892469;0.006580721527935406;0.769162383550154;[BRCA1]
GO:0071456;cellular response to hypoxia;6.0;1.0;0.8231203125901445;9.628524252492122;103.24589989147204;5.104244793218563;0.0034555473540902374;0.5841516286869992;[NPEPPS, SFRP1, CCNB1, TBL2, LMNA, UBQLN1, RORA, HYOU1, ATP7A, KCNK3, SIRT2]
GO:1900100;positive regulation of plasma cell differentiation;10.0;1.0;0.9152410118609203;9.628524252492122;1100.5446703066416;9.777073627680469;0.036834239689263915;0.9152410118609203;[XBP1]
GO:1901796;regulation of signal transduction by p53 class mediator;7.0;0.7192862368539868;0.710562483684194;9.117698628726131;45.070113835906206;4.948759890378168;0.001508456149618737;0.6039991761920099;[NUAK1, TBP, CSNK2A1, RPS7, TP53INP1, CDK2, TRIM24, TP53BP2, EP300, TAF7, SENP2, RFFL]
GO:0006893;Golgi to plasma membrane transport;7.0;0.8933024483968273;0.7975705894556142;9.510741216835738;32.11060110714162;5.845247994956144;0.0010747129213912287;0.6498456195510879;[BBS2, ARF3, ARFGEF2, SYS1, VAMP5, EXOC1]
GO:1900103;positive regulation of endoplasmic reticulum unfolded protein response;8.0;0.8653626801206646;0.8076813400603323;9.481920778300246;307.4132605156266;7.212124270218933;0.010288845175485454;0.7438283705770736;[ERN1, XBP1]
GO:0006897;endocytosis;5.0;0.6324783794010864;0.6064802015614634;8.088079211544972;26.35802846831835;3.582668236575797;8.821794921490709E-4;0.47345883209051776;[COLEC12, DGKD, CD163L1, TFRC, WIPF2, ITGB3, ITGB2, STON1, CLTA, FNBP1L, RABEPK, LRP8, CORO1A, TM9SF4, HSP90B1, CLN3, KIAA1109, AP2S1, APOL1, SCARF1, FCER1G, AMBP, FNBP1, CDC7, UNC13D, MARCH3, NME1, RUFY1, GAK, SYNJ1, CDK5, SNX17, CD9, PIK3C3, HYOU1, DOCK2, CSNK1G2, CSNK1G1]
GO:0006414;translational elongation;6.0;0.7671156992804218;0.7066781622303554;9.117698628726131;105.15840431616243;4.981283082083729;0.0035195571560423886;0.5778633610612594;[EFTUD2, EEF1B2, HBS1L, MRPL40, MRPS24, MRPS36, MRPS22, MRPS18A, MRPL17]
GO:0006898;receptor-mediated endocytosis;6.0;0.6799073451904818;0.6630739851853854;8.48339194818912;28.437470009997963;4.178651668682095;9.517765291732001E-4;0.536816753253722;[COLEC12, FCER1G, CD163L1, TFRC, AMBP, ITGB2, CLTA, FNBP1L, RABEPK, LRP8, HSP90B1, GAK, CLN3, SYNJ1, SNX17, AP2S1, CD9, HYOU1, APOL1, SCARF1]
GO:0006656;phosphatidylcholine biosynthetic process;8.0;0.7980440201809971;0.7740220100904985;9.398000593880289;749.286726231254;6.343086423195323;0.025077952412686653;0.6993857346658935;[FABP5, STARD10]
GO:0006412;translation;7.0;0.8653626801206646;0.7836007053175329;9.510741216835738;402.5585345733233;4.39257856489138;0.01347327187300917;0.5755560373415389;[RPL39L, HBS1L, RPS9, NDUFA7, RPL3, MRPS24, RPS7, MRPS36, MRPS18A, RRBP1, RPL23A, RPL3L, RPS15, COPS5, RPL36AL, RPL22L1, RPL29, RPL19, CPEB4]
GO:0071681;cellular response to indole-3-methanol;6.0;1.0;0.8231203125901445;9.628524252492122;467.4090985487011;8.16763571524637;0.01564376188754665;0.7408135829017477;[BRCA1]
GO:0006888;ER to Golgi vesicle-mediated transport;6.0;1.0;0.8231203125901445;9.628524252492122;49.13394272044514;4.493869898942481;0.001644468845175705;0.5529370282083849;[DCTN6, DCTN5, COPB2, COPA, DCTN4, GOSR1, DCTN3, KLHL12, RAB43, SPAST, TFG, TMED2, STX5, TMED1, TMED4, TRAPPC2, TRAPPC3, TMED9, COG4, COG3, COG1, DYNLL2, SPTB, ARFGAP1, ARCN1, TBC1D20, TRAPPC6B, GOLGB1, HYOU1, SEC24C, SEC22C]
GO:0030970;retrograde protein transport, ER to cytosol;10.0;1.0;0.9152410118609203;9.628524252492122;126.6472701115644;7.004484905440688;0.004238770155490853;0.7734506956670166;[NPLOC4, SYVN1, DERL2, HSP90B1]
GO:0035067;negative regulation of histone acetylation;11.0;0.811012628672052;0.8379352666656883;9.498471124243924;1304.334881216342;6.943860283624253;0.04365491464912905;0.7875382901567328;[TAF7, BRCA1]
GO:0048699;generation of neurons;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;21.75937296335754;7.474488534686424;7.282666309192915E-4;0.6724867031240476;[THOC2, CIT]
GO:0006744;ubiquinone biosynthetic process;7.0;0.8259837884571596;0.7639112594857803;9.405380701177911;357.5406619598991;7.004484905440688;0.011966564190092859;0.7091290490632969;[COQ3, COQ10B]
GO:0006983;ER overload response;6.0;0.8653626801206646;0.7558016526504768;9.434368238051164;81.5596405220072;7.379178354882098;0.002729727769360572;0.7004918368257019;[WFS1, EIF2AK3]
GO:0000079;regulation of cyclin-dependent protein serine/threonine kinase activity;11.0;0.7866048967936545;0.8257314007264895;9.474373572664863;340.6851601099881;5.181953777545879;0.011402425712143147;0.6974343094988531;[CDKN1A, CCNB1, CDKN2C, CCNE2, CCNH, CCNE1, CCNF, PKMYT1, CDC25A, CCNJL, CKS1B]
GO:0006984;ER-nucleus signaling pathway;5.0;0.7980440201809971;0.6892630219514189;8.935377071932177;23.17027026302992;6.221725566191056;7.75488093814194E-4;0.6084203466557585;[XBP1, WFS1, EIF2AK3, SCAP, ATP2A2, ERLIN2, HSP90B1]
GO:0006978;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;8.0;1.0;0.875;9.628524252492122;145.46952913610525;7.004484905440688;0.004868734226108882;0.7332096838060964;[CDKN1A, BRCA1]
GO:0071230;cellular response to amino acid stimulus;6.0;0.7140352122741334;0.6801379187272112;8.962045319014338;283.89643900763554;5.6339389012889365;0.009501758323378283;0.6112402100070131;[XBP1, COL1A2, ATP7A, CPEB4]
GO:0006855;drug transmembrane transport;5.0;0.5781283279524737;0.5793051758371571;7.293149336675085;29.084245973375534;5.407625775213448;9.73423538606871E-4;0.5667872454856517;[EBP, TMEM30A, ABCC2, ARL6IP5, SLC25A10, NTSR1]
GO:0006614;SRP-dependent cotranslational protein targeting to membrane;12.0;1.0;0.9481203125901445;9.628524252492122;336.65241395888097;5.288437257948329;0.011267453327701498;0.718571239899105;[RPS15, RPS9, RPL3, RPS7, SRP54, RPL23A, RPL29, RPL19]
GO:0006977;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;11.0;1.0;0.9324289523296623;9.628524252492122;888.119660647831;5.75172193694532;0.0297245657860804;0.7265722796674696;[BTG2, CDKN1A, CNOT10, CNOT4, CNOT6, CCNB1, TFDP2, CNOT1, CNOT3, CDK2, CASP2, EP300, CNOT8, GTSE1, E2F7, E2F8]
GO:0000086;G2/M transition of mitotic cell cycle;5.0;1.0;0.7902410118609202;9.628524252492122;43.44612409677276;4.981283082083729;0.0014541026745458175;0.5449840603320351;[CDKN1A, DCTN3, FBXL15, PKMYT1, MASTL, TUBG1, CKAP5, CDC25A, CIT, CCNB1, PPME1, CENPJ, CEP70, CDK2, SKP2, MAPRE1, CLASP1, PAFAH1B1]
GO:0030968;endoplasmic reticulum unfolded protein response;5.0;0.8653626801206646;0.7229223519212526;9.387362195675234;54.36536464462378;5.142344639450834;0.0018195598290039001;0.5532207558659172;[ZBTB17, XBP1, WFS1, EDEM1, DERL3, SYVN1, EIF2AK3, DERL2, ARFGAP1, HSP90B1, ERN1, CREB3, EXTL2, TBL2, CTDSP2, LMNA, DNAJB11, TPP1, HYOU1]
GO:0000083;regulation of transcription involved in G1/S transition of mitotic cell cycle;10.0;0.8933024483968273;0.861892236059334;9.541512875502493;264.067998117236;6.444869117505266;0.008838118251214853;0.7448319182472036;[TFDP2, CCNE1, GFI1, FBXO5, E2F7]
GO:0000082;G1/S transition of mitotic cell cycle;5.0;1.0;0.7902410118609202;9.628524252492122;42.752976916212816;5.142344639450834;0.0014309036622044387;0.5532207558659172;[CDKN1A, CDKN2C, MAX, GMNN, MCM10, CDC7, CDC25A, POLE4, PPP6C, GPR132, CCNE2, CCNE1, POLE2, CDK2, MCM6, SKP2, MCM2]
GO:0071353;cellular response to interleukin-4;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;6.599019797332524;0.0027327542132076126;0.6605944919115335;[TUBA1B, XBP1, RPL3, IMPDH2, CORO1A, MCM2]
GO:0071356;cellular response to tumor necrosis factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;4.973052582947213;0.0027327542132076126;0.5774424529526606;[ABCC2, CCL20, CIB1, RORA, BRCA1, THBS1, TANK, NFKB1, RELA, SFRP1, CCL5, RIPK1, CCL19]
GO:0016311;dephosphorylation;5.0;0.6835726970475526;0.6320273603846966;8.32924126836186;24.405590426795786;4.076630054289783;8.168331479794688E-4;0.4987200624199847;[PNKP, PTPN22, PPM1G, DUSP14, PPP1CB, POLB, PPP2CA, PPP1CC, PPP6C, NT5DC2, ACP2, DUSP5, EYA2, SSU72, DUSP28, PPP2R5D, SSH3, SGPP2, CDC25A, PTP4A1, DUSP22, DUSP23, G6PC3, SYNJ1, PTPRA, CTDSP2, IMPAD1]
GO:2000059;negative regulation of ubiquitin-dependent protein catabolic process;10.0;0.8259837884571596;0.8282329060895002;9.510741216835738;1664.7506957432736;6.039404009397101;0.05571770760817117;0.7240964137624963;[RPS7, CLEC16A, PBK]
GO:0051865;protein autoubiquitination;10.0;1.0;0.9152410118609203;9.628524252492122;155.4032479663248;5.769740442447999;0.005201206855589802;0.7103058064080809;[CNOT4, ITCH, RNF213, UBE2B, DTX3L, UBE2T, BRCA1]
GO:0060333;interferon-gamma-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.514393750639154;0.00101047745553359;0.6329257181104212;[CIITA, IRF4, HLA-DPB1, NCAM1, HLA-A, HLA-DRB3, HLA-F, HLA-DQA1, HLA-DPA1]
GO:0060691;epithelial cell maturation involved in salivary gland development;5.0;1.0;0.7902410118609202;9.628524252492122;40.65746374130209;9.777073627680469;0.001360768722079595;0.7902410118609202;[XBP1]
GO:0006750;glutathione biosynthetic process;8.0;1.0;0.875;9.628524252492122;528.5812657394678;7.069023426578259;0.017691139272045377;0.7365101867784198;[CHAC2]
GO:0006751;glutathione catabolic process;7.0;1.0;0.8509193652572005;9.628524252492122;452.007296405459;7.379178354882098;0.015128277430534352;0.728290889492758;[CHAC2]
GO:0006990;positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response;13.0;1.0;0.9625549647676366;9.628524252492122;1470.606783206999;8.67846133901236;0.04921988557375968;0.9063718812344532;[CREB3, XBP1, EP300]
GO:1901215;negative regulation of neuron death;6.0;0.7586651285174919;0.7024528768488905;9.05316010758856;58.54459561550999;4.545965010825883;0.001959434928535777;0.5556011746527726;[BTG2, WFS1, PARP2, NONO, KIF14, CORO1A, CLN3, CDK5, PSMC1, CHMP4B, KRAS, HYOU1, ADNP, SNCB, CPEB4]
GO:1903874;ferrous iron transmembrane transport;10.0;0.8933024483968273;0.861892236059334;9.523163736834295;160.1462887143258;8.390779266560578;0.005359952160965854;0.8443458537639685;[SLC39A14]
GO:0006633;fatty acid biosynthetic process;8.0;0.6493065804076676;0.6996532902038338;8.912904216080118;359.8485513982277;5.076593261888053;0.01204380717262807;0.6346172154986847;[ACLY, XBP1, ACOT7, ELOVL5, DEGS1, ELOVL6, BRCA1, HSD17B8, PRKAB1, FADS1, MGLL]
GO:1903515;calcium ion transport from cytosol to endoplasmic reticulum;10.0;1.0;0.9152410118609203;9.628524252492122;157.63288055440037;9.777073627680469;0.005275830651773637;0.9152410118609203;[ATP2A2]
GO:0034080;CENP-A containing nucleosome assembly;9.0;1.0;0.896240625180289;9.628524252492122;242.74046782674554;6.343086423195323;0.00812430500592325;0.7206263598461826;[CENPH, CENPK, OIP5, CENPP, ITGB3BP]
GO:0006511;ubiquitin-dependent protein catabolic process;8.0;0.7369933605727446;0.7434966802863723;9.190269321560967;156.4521708431119;3.582668236575797;0.005236313360306564;0.5582178202295975;[USP36, PPP1R11, USP32, CCNF, USP34, KIF14, BUB1B, UBE2Z, UBE2L3, PSMD8, TRIM9, PSMD7, PSMD4, PSMD2, CDC26, SKP2, C18orf25, USP46, SEC13, RNF44, FBXO18, DTX3L, ARRDC1, RAD23A, TRPC4AP, KCTD5, SIRT2, DDB1, PSMA1, KCTD10, TBL1XR1, ANAPC5, MAN1B1, USP41, DERL3, RNF38, USP12, UBR4, DERL2, NEDD8, PSMB10, PSMA7, ANAPC11, ARNTL, HSP90B1, CCNB1, RNF213, PSMB5, TP53INP2, UBD, PSMB1, UBQLN1, USP51, RFFL, RNF20, XBP1, UBE2I, LRRC29, UBE2B, KLHL25, WFS1, EDEM1, SYVN1, FBXL15, ERLIN2, FBXL16, KBTBD4, NSFL1C, ITCH, SPSB1, RNF103, NPLOC4, PSMC1, FBXL3, TRIM32, MAD2L1]
GO:0060337;type I interferon signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.587418885654044;0.00101047745553359;0.6366602269110988;[IFNAR2, IRF4, HLA-A, HLA-F]
GO:0006868;glutamine transport;10.0;0.8933024483968273;0.861892236059334;9.4949928598676;85.82177420350179;8.16763571524637;0.0028723775480089153;0.8329342821725234;[SLC1A4]
GO:0002026;regulation of the force of heart contraction;7.0;0.7192862368539868;0.710562483684194;8.763526815005518;26.867502833526505;6.444869117505266;8.992311406554274E-4;0.6805102716434839;[ATP2A2]
GO:0070372;regulation of ERK1 and ERK2 cascade;10.0;0.8653626801206646;0.8479223519212526;9.541512875502493;158.98679164778278;4.069963362931594;0.0053211448376282704;0.623379127513894;[PDGFRB, ERRFI1, FGA, CCL20, FGG, GPR55, CIB1, PTPN22, IGF1R, RAP1B, FLCN, CD4, NLRP12, KARS, RRAS, CCL5, CSK, CCL19, EPHA1, FAM83D, HAVCR2]
GO:0045086;positive regulation of interleukin-2 biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;7.292166977892469;0.027942676825076673;0.747921758369865;[CD4, IRF4, CD80, GLMN]
GO:0071222;cellular response to lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;237.99812851129587;4.786641040901733;0.007965583176863442;0.5679093580234316;[UPF1, XBP1, ABCC2, CCL20, GFI1, CD80, PDCD1LG2, NFKB1, RELA, BCR, IL6, PABPN1, NLRP7, TBXA2R, TNIP2, NLRP3, IL12A, HAVCR2]
GO:0048478;replication fork protection;10.0;1.0;0.9152410118609203;9.628524252492122;1135.309178205509;7.57984905034425;0.037997776482613155;0.8028748447945538;[TIPIN, FBXO18, TIMELESS, DONSON]
GO:0097711;ciliary basal body-plasma membrane docking;5.0;1.0;0.7902410118609202;9.628524252492122;21.38880323109876;5.223196736079928;7.158639954716971E-4;0.5573555358475362;[CENPJ, CEP70, RAB3IP, DCTN3, MAPRE1, TUBG1, CKAP5, CLASP1, RAB11A, PAFAH1B1]
GO:0045082;positive regulation of interleukin-10 biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;9.083926447120524;0.027942676825076673;0.839552420951524;[IRF4, BCL3]
GO:0045927;positive regulation of growth;4.0;0.5960880403619941;0.5480440201809971;7.431299675155902;22.17287423474559;4.259620731215762;7.421061463456658E-4;0.46783720228699566;[BBS2, MTPN, CSNK2A1, WFS1, PARP2, SPHK1, H3F3A, DERL2, CIB1, RAB11A, VIL1, NIPBL, SFRP1, CCNB1, RUFY3, ADNP, TRIM32, EIF4G2, PAFAH1B1, HBEGF]
GO:0015031;protein transport;7.0;0.4793097133439409;0.590574221929171;6.989466922876863;54.45792783373929;2.578890050578526;0.0018226578356421344;0.4828039223744382;[RAB3B, AHCYL1, SYS1, RPL3, DGKD, TFRC, NCF1, ZDHHC6, IPO4, RAB43, RPH3A, RPS15, EIF4ENIF1, IPO8, LAMP2, LONP2, ARFIP1, HOMER3, TBC1D22A, VPS18, GSTK1, RPS9, RPS7, ARRDC1, VPS33A, COG4, VPS33B, COG3, AP1B1, COG1, TBC1D2B, MYO7A, SYTL3, BCR, RUFY1, UNC50, CHMP4B, KIF20A, RPL29, SLC27A2, KPNB1, ACOT4, PPID, COPB2, COPA, SUCNR1, VPS26B, ABCB9, HSP90B1, VPS8, VPS11, NLRP3, ECT2, RAB6A, ATP6V1F, VPS16, BBS2, XBP1, TOR1A, PMM1, VTA1, RAB3IP, NUP153, RAB27B, TIMM44, NFKBIA, PAN3, NPLOC4, CDK5, BCL3, HYOU1, ARF3, TRAM1, AHCTF1, SFT2D3, YWHAB, SRP54, CLTA, LYST, TRAM2, AP1G2, AP1G1, NUP62, KIF13B, TMED2, TMED1, EVI5L, TNPO1, TNPO2, SNAP29, RAB8B, TMED4, GRIPAP1, TMED9, SEC13, PDCD6IP, DTX3L, SSR2, RHBDF2, FGG, TBC1D8, BTN3A2, SENP2, ARFGAP1, AFTPH, GAL, ACOX2, AGPS, EXOC3, LCP2, CHMP6, SLU7, VAMP5, PAFAH1B1, EXOC1, SEC22C, RABGAP1, GOSR1, ZDHHC23, HSD17B4, ZDHHC24, DERL2, RRBP1, NLRC4, TRAK1, RGPD1, NAPG, STX11, ARNTL, RAB21, AP3M1, RAB20, GGA3, SNX25, LMNA, VPS52, AP2S1, HEATR3, STX5, VPS54, CCL19, RAB28, BID, RAE1, RPL19, PEX16, TIMM8B, ARFGEF2, PEX19, SYVN1, RPL23A, RAB11A, ARCN1, CENPF, SPCS2, MCM3AP, SNX19, SNX17, SNX14, VPS41, RAB13, TAOK2, RAB18, RUNDC1, RAB3GAP2, APBA3, SEC24C]
GO:1903489;positive regulation of lactation;7.0;0.9326813400603323;0.8172600352873667;9.571365838652174;160.4352972466691;8.67846133901236;0.005369625016452592;0.7947362817240173;[XBP1]
GO:0042531;positive regulation of tyrosine phosphorylation of STAT protein;11.0;1.0;0.9324289523296623;9.628524252492122;1230.2749798860389;5.618190544320798;0.04117619640118775;0.7197434780388068;[IL6, IL23A, CCL5, IL12A]
GO:0030308;negative regulation of cell growth;6.0;0.6913464685778243;0.6687935468790567;8.673012807464685;80.89021177018715;4.623782033182691;0.0027073225914839173;0.5595807407949613;[SEMA6B, CDKN1A, CDKN2C, EAF2, ADIPOR2, PPP2CA, FLCN, SERTAD3, SFRP1, GAL, CDK5, SERTAD2, NPPA]
GO:0032729;positive regulation of interferon-gamma production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;5.6339389012889365;0.002183412136085803;0.6112402100070131;[IL23A, BCL3, EBI3, HLA-DPB1, PTPN22, IL27, IL12A, CD244, CCR2, HLA-DPA1, HAVCR2]
GO:0018312;peptidyl-serine ADP-ribosylation;9.0;1.0;0.896240625180289;9.628524252492122;311.084127669241;8.67846133901236;0.010411705795550976;0.8400575416471059;[PARP2]
GO:0019886;antigen processing and presentation of exogenous peptide antigen via MHC class II;5.0;1.0;0.7902410118609202;9.628524252492122;42.20009821028515;5.192106149009898;0.0014123993094755708;0.5557655617789146;[DCTN6, DCTN5, DCTN4, DCTN3, CLTA, KLC1, KIF15, HLA-DMA, HLA-DMB, AP1G1, AP2S1, CTSE, HLA-DQA1, HLA-DPA1, LAG3, SEC13, FCER1G, AP1B1, KIF23, DYNLL2, CENPE, KIF4A, HLA-DPB1, KIF2C, HLA-DRB3, SEC24C]
GO:1902042;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;10.0;0.9326813400603323;0.8815816818910864;9.589303539338841;425.73912115989816;6.193554689224359;0.014249105244888325;0.731979686697602;[FGA, FGG, RIPK1, TNFRSF10A, BRCA1, RFFL]
GO:0045814;negative regulation of gene expression, epigenetic;7.0;0.7671156992804218;0.7344772148974115;9.081980546124052;80.1036275103501;5.2552850506314295;0.0026809963241870454;0.6196748871422394;[HELLS, HIST3H2A, HDAC1, MTF2, H3F3A, SUPT6H, SIRT2, EZH2, PHF19]
GO:0014075;response to amine;5.0;0.7980440201809971;0.6892630219514189;9.223059144383958;29.79647000066773;6.139487467954083;9.972610358403309E-4;0.6042146864874571;[OXTR, ITGA2, CAD, NME1]
GO:0006695;cholesterol biosynthetic process;7.0;0.8653626801206646;0.7836007053175329;9.50592193039979;430.3580998185219;6.039404009397101;0.014403698303781551;0.6597747671587765;[ACLY, SQLE, EBP]
GO:0006574;valine catabolic process;9.0;0.8933024483968273;0.8428918493787028;9.5544162803384;931.900707380216;8.390779266560578;0.031189878019829358;0.8253454670833372;[HIBCH]
GO:0051382;kinetochore assembly;6.0;1.0;0.8231203125901445;9.628524252492122;123.98170582545;7.212124270218933;0.004149556117686715;0.6919486831672181;[CENPE, CENPF, CENPH, CENPK]
GO:0008630;intrinsic apoptotic signaling pathway in response to DNA damage;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;84.23129647150353;5.54296712308321;0.002819145689655962;0.6343869617060081;[POLB, CDKN1A, BCL3, DDIT4, CASP2, EP300, BRCA1]
GO:0009967;positive regulation of signal transduction;6.0;0.44130843764162375;0.5437745314109563;6.712834686611667;140.23187634019237;2.4492930892588385;0.004693434700611163;0.44837727507861835;[NCF1, MAML1, GFI1, CD80, CIB1, IGF1R, TFG, ARL6IP5, EP300, IL12A, SKP2, PDGFRB, CSNK2A1, FBXO18, IGFBP5, RPS7, SLC35C2, MAPK8IP3, ERN1, DEPDC1B, SFRP1, TWSG1, KARS, IL23A, TBL1XR1, EPHA1, ANKRD17, SEH1L, CLEC16A, RASGRP4, STK3, MTDH, C3, RAP1B, UBD, TP53BP2, DVL3, RIPK1, ECT2, NTSR1, CREBBP, XBP1, UBE2I, STARD10, TNFRSF10A, NFKB1, IL6, CDK5, CALM3, SERINC3, CALM1, CALM2, EZH2, CDKN1C, HRK, BCAR3, YWHAB, ITGB3, USP34, PTPN22, BBC3, FLCN, AKAP13, C1QBP, NUP62, CASP2, CTSH, DACT1, HAVCR2, TMED4, FGA, DUSP5, SEC13, KSR1, BUD31, SPHK1, ATPIF1, FGG, PLAUR, ZFP91, ARNT, ZDHHC13, YWHAZ, VAV1, ITPKB, DUSP22, ALS2, TFDP2, ARHGEF5, PAFAH1B1, HBEGF, BECN1, HDAC3, WBP2, SLC20A1, THBS1, RELA, ARNTL, BCLAF1, CCL5, TP53INP1, CSK, ZNF622, CCL19, BID, TBX1, MAP3K3, PDE6H, CCL20, GPR55, G0S2, FBXL15, CD4, NLRP12, P2RX4, TNIP2, TSPAN17, TAOK2, KRAS, TRIM32, LIMS1]
GO:0098586;cellular response to virus;6.0;0.7763722522362496;0.7113064387082693;8.999915593069748;28.654098265158677;6.375876246018314;9.59026881920657E-4;0.6491829203200885;[IL12A, CCL19, TMEM173]
GO:0051135;positive regulation of NK T cell activation;10.0;0.9326813400603323;0.8815816818910864;9.589303539338841;288.14718947343493;7.697632086000634;0.009644027116041537;0.8088982747154926;[IL23A, IL12A]
GO:0051256;mitotic spindle midzone assembly;5.0;1.0;0.7902410118609202;9.628524252492122;55.94550109770304;7.474488534686424;0.001872445574057981;0.6724867031240476;[KIF4A, KIF23]
GO:0010829;negative regulation of glucose transmembrane transport;7.0;0.8933024483968273;0.7975705894556142;9.533214072687796;65.66986041637082;6.832634648514029;0.002197911129098591;0.7003406189322132;[FABP5]
GO:0031508;pericentric heterochromatin assembly;7.0;1.0;0.8509193652572005;9.628524252492122;98.72405253680223;8.67846133901236;0.0033042051925278506;0.7947362817240173;[HELLS, H3F3A]
GO:0061051;positive regulation of cell growth involved in cardiac muscle cell development;10.0;1.0;0.9152410118609203;9.628524252492122;1867.0563873166498;7.697632086000634;0.06248869704183021;0.8088982747154926;[PARP2]
GO:1903382;negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway;11.0;1.0;0.9324289523296623;9.628524252492122;1191.816965339143;9.083926447120524;0.03988904126426917;0.8969813732811862;[HYOU1]
GO:0002181;cytoplasmic translation;8.0;1.0;0.875;9.628524252492122;403.65714686199146;5.825829909099042;0.013510041437624024;0.6729332124801218;[RPS7, RPL22L1, RPL29, RPL19]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[CRTC2, MAML1, CCNH, GFI1, ARID4A, RORA, IKZF1, IKZF2, ELK1, YY1, RPS6KA4, DPF2, EP300, SOX8, IER5, ZNF564, IER2, FLT3LG, MED6, RUNX2, PIAS2, ARMCX3, IL23A, TBL1XR1, RFX4, HOXB4, MAX, RLF, SUPT6H, RAD21, HLTF, SCAP, NLRP3, HOXC4, RIPK1, CYTL1, TFAP2A, ZBTB17, ZNF143, DR1, CREBBP, XBP1, PBX3, EAF2, ERLIN2, FLI1, NFKB1, SETX, CDK9, NFKBIA, IL6, STAG1, TFCP2, COPS5, SP1, SP3, MAFF, BCL3, NFE2L1, CIITA, SETD3, ONECUT2, ELL, DDX41, HOXC13, BRCA1, AATF, FLCN, NIPBL, ZNF485, KLF13, PEG3, NCOA6, MKL1, ARNT, SENP2, SAFB, TMEM173, PPRC1, SIRT2, CREB3, GAL, TFDP2, ELF4, IRF4, MTF2, TFEC, HDAC3, ZNF350, HDAC1, WBP2, RELA, ARNTL, RXRA, MTA2, E2F7, E2F8, TBX1, ZNF462, NFYC, ATAD2, ARID3B, GRHL1, USF2, NFIB, TNIP2, NFIC, PSMC1, TAF7, CAMK1]
GO:0006303;double-strand break repair via nonhomologous end joining;9.0;0.8933024483968273;0.8428918493787028;9.548481544818586;368.8093148901945;5.8067817141283475;0.012343715862540626;0.693199712083778;[POLQ, DCLRE1C, XRCC5, BRCA1]
GO:0006301;postreplication repair;8.0;0.8259837884571596;0.7879918942285797;9.500690880982237;183.0506323445446;5.8067817141283475;0.006126539929698291;0.6719590869034888;[RFC3, NPLOC4, RFC4, UBE2B, POLE2, BRCA1]
GO:0043524;negative regulation of neuron apoptotic process;8.0;0.7866048967936545;0.7683024483968273;9.245532000236016;179.62959498689688;4.864418741944418;0.006012040888071555;0.6237666006816429;[CLN3, BTG2, WFS1, NONO, KIF14, KRAS, HYOU1, ADNP, SNCB, CORO1A, CPEB4]
GO:0045822;negative regulation of heart contraction;7.0;0.7369933605727446;0.7194160455435727;9.040737587590003;64.41637939842661;6.686031174322154;0.002155958247487675;0.692843310444282;[ATP2A2]
GO:0051024;positive regulation of immunoglobulin secretion;9.0;1.0;0.896240625180289;9.628524252492122;579.4559284816147;7.379178354882098;0.019393868449801132;0.7736121494158466;[IL6, XBP1]
GO:0051383;kinetochore organization;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;38.75571468247735;6.8867018697843045;0.0012971188925437662;0.6424272657460779;[CENPE, CENPF, CENPH, NUF2, CENPK, SMC4, NDC80, SMC2]
GO:0032700;negative regulation of interleukin-17 production;6.0;0.8653626801206646;0.7558016526504768;9.427853557029971;65.25422870398782;7.292166977892469;0.002184000309729388;0.6960420709600095;[NCKAP1L, IL12A]
GO:0030521;androgen receptor signaling pathway;8.0;0.8933024483968273;0.8216512241984136;9.446202695698167;54.01143535742291;5.948432231191374;0.0018077141342769656;0.6792031009335148;[CCNE1, BRCA1, ARID1A, PIAS2]
GO:0016579;protein deubiquitination;9.0;0.7307253602413294;0.7616033053009538;9.151600180401813;202.59641706362558;4.174954806800768;0.0067807197541817285;0.6097480081553338;[BECN1, USP36, WDR48, USP32, USP12, USP34, OTUD7B, NEDD8, BRCA1, USP39, PSMB10, PSMA7, YY1, PSMD8, POLB, VCPIP1, TFPT, RHOT1, PSMD7, PSMB5, PSMD4, PSMD2, PSMB1, NLRP3, USP51, RIPK1, SKP2, USP46, RAD23A, JOSD1, CDC25A, NFKBIA, COPS5, PSMA1, TNIP2, PSMC1, PSME2, USP41]
GO:0045717;negative regulation of fatty acid biosynthetic process;8.0;0.8436909121759173;0.7968454560879586;9.480104247373848;670.1384648150137;7.138016298065211;0.022428931331895798;0.7400384854347593;[ERLIN2, BRCA1]
GO:0007517;muscle organ development;4.0;0.7763722522362496;0.6381861261181248;8.753055515138222;27.682183388997124;5.085725745451326;9.264977656821302E-4;0.5100842511328143;[TBX1, FXR1, CENPF, XBP1, VAMP5, HBEGF]
GO:1990036;calcium ion import into sarcoplasmic reticulum;10.0;1.0;0.9152410118609203;9.628524252492122;110.23571382491266;9.777073627680469;0.003689490136018364;0.9152410118609203;[ATP2A2]
GO:0010923;negative regulation of phosphatase activity;9.0;0.7866048967936545;0.7895430735771163;9.362821086759116;265.75489588375854;5.142344639450834;0.008894577201350937;0.659220369185286;[MYO1D, ELL, PPP1R11, ROCK2, PPME1, CD2BP2, PHACTR2, NCKAP1L, PKMYT1, MASTL]
GO:0032816;positive regulation of natural killer cell activation;8.0;0.8259837884571596;0.7879918942285797;9.446202695698167;160.32529438548238;6.943860283624253;0.00536594331968482;0.7301093378270707;[IL23A, AP1G1, FLT3LG, IL12A]
GO:0085020;protein K6-linked ubiquitination;11.0;1.0;0.9324289523296623;9.628524252492122;157.60047254366168;7.697632086000634;0.00527474598481953;0.8260862151842345;[UBE2T, BRCA1]
GO:0003091;renal water homeostasis;7.0;1.0;0.8509193652572005;9.628524252492122;57.14336741787613;6.311337724880743;0.0019125370817844765;0.6736814700148209;[WFS1, RAB11A]
GO:1902476;chloride transmembrane transport;8.0;1.0;0.875;9.628524252492122;110.5175749436453;5.311165509025885;0.0036989237740038075;0.6466132511260384;[CLIC5, SLC1A4, CLCC1, CLCN3, APOL1, BEST3]
GO:0006241;CTP biosynthetic process;11.0;0.8933024483968273;0.8790801765280758;9.598218902996793;8934.402720436805;7.138016298065211;0.29902641861260104;0.7974674377644215;[UCK2, NME1]
GO:0006366;transcription by RNA polymerase II;10.0;0.6039883530135606;0.7172351883677006;8.613793447804714;583.8786478812184;3.2909128387363804;0.01954189288791682;0.5835384474769965;[ONECUT2, ELL, CCNH, INTS10, ARID4A, HOXC13, BRCA1, ELK1, AFF4, TRIM24, ZNF768, EP300, IER2, GTF2I, TBP, KLF13, MKL1, ZBTB32, ARNT, CREB3, NCOR1, TFDP2, ELF4, IRF4, RFX4, TFEC, MED20, LCOR, WBP2, MAX, RPAP1, SUPT6H, GTF2E2, RELA, ARNTL, POLR2B, RAD21, TAF1A, HLTF, HIVEP1, HOXC4, POLR2G, HIVEP2, TFAP2A, POLR2J3, ZBTB17, ZNF143, XBP1, NFYC, INTS3, PBX3, EAF2, ARID3B, DEK, GRHL1, USF2, GTF2H4, FLI1, NFKB1, CDK9, GFI1B, STAG1, TFCP2, COPS5, SP1, NFIB, NFIC, MAFF, NFE2L3, INTS4, TAF7, NFE2L1]
GO:0006487;protein N-linked glycosylation;8.0;0.7980440201809971;0.7740220100904985;9.34084218004034;176.5615275388073;5.500407508664414;0.005909355431665436;0.6562910957882058;[PMM1, DERL3, MGAT4B, RPN1, SYVN1, STT3A, PGM3, MGAT3]
GO:0006364;rRNA processing;9.0;0.6347111282356054;0.7135961892980918;8.681142933547935;356.38664419027253;4.478756261132433;0.01192794025389202;0.6252844286580675;[RPS15, RPS9, WDR37, LAS1L, RPS7, POP4, EIF4A3, IMP4, EXOSC3, BYSL]
GO:1902236;negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway;10.0;0.9326813400603323;0.8815816818910864;9.596775554177542;830.7594506111926;6.832634648514029;0.02780477117699164;0.7646622655359331;[CREB3, XBP1, WFS1, SYVN1, HYOU1]
GO:0006006;glucose metabolic process;6.0;0.7090535922965819;0.6776471087384355;8.572471578242808;34.676020684410545;5.040875179285974;0.0011605752059146955;0.5809109036834981;[CRTC2, TPI1, IGFBP5, ADPGK, BPGM, PER2, NISCH, HK3, G6PC3, ALDH5A1, FABP5, SLC25A10, ALDOA]
GO:0042853;L-alanine catabolic process;11.0;0.8436909121759173;0.8542744084176208;9.4949928598676;645.4217339376786;8.390779266560578;0.021601684593045005;0.8615337942327104;[GPT2]
GO:0006488;dolichol-linked oligosaccharide biosynthetic process;6.0;1.0;0.8231203125901445;9.628524252492122;80.91159753301743;7.069023426578259;0.00270803835371991;0.6846304993685643;[ALG14]
GO:0006368;transcription elongation from RNA polymerase II promoter;9.0;1.0;0.896240625180289;9.628524252492122;477.15162764714074;5.459585514144159;0.015969835568764485;0.675444082270312;[CDK9, ELL, POLR2B, CCNH, EAF2, POLR2G, SUPT6H, GTF2H4, AFF4]
GO:0072383;plus-end-directed vesicle transport along microtubule;9.0;0.9326813400603323;0.8625812952104552;9.584072489921288;265.6185688795062;7.8311634786251565;0.00889001445920495;0.7967266896635242;[KIF23]
GO:0097202;activation of cysteine-type endopeptidase activity;12.0;1.0;0.9481203125901445;9.628524252492122;669.1123145181327;7.212124270218933;0.0223945870049345;0.8169486831672182;[PERP]
GO:0016055;Wnt signaling pathway;7.0;0.5916390046238794;0.6467388675691402;7.647522783625538;28.581916314885376;4.0633408221711;9.566110170045473E-4;0.558718803867703;[TLE4, CSNK2A1, UBE2B, USP34, KLHL12, SENP2, APCDD1, DDB1, SFRP1, GNG2, GNAT2, CCNE1, AP2S1, DVL3, SDC1, TAX1BP3, CALM1, MARK2, CSNK1G2, DACT1, CSNK1G1]
GO:0010976;positive regulation of neuron projection development;9.0;0.6763753087927167;0.7344282795766475;9.14017148457819;493.1928131726474;4.231896183200907;0.016506719612173492;0.6126599927924817;[ACTR2, TMEM30A, TRAK1, LRP8, RAB11A, NME1, RAB21, SETX, FES, RUFY3, CAPRIN1, DVL3, CAMK1, ADNP, SCARF1, MARK2, PAFAH1B1, EZH2]
GO:0032760;positive regulation of tumor necrosis factor production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;85.9095484537234;5.587418885654044;0.002875315273172136;0.6366602269110988;[ARFGEF2, FCER1G, IL23A, RIPK1, CCL19, THBS1, CCR2, HAVCR2]
GO:1900182;positive regulation of protein localization to nucleus;7.0;0.8436909121759173;0.7727648213451592;9.36615998802463;74.62336946219564;5.446340287394138;0.0024975770192273523;0.6294454608352614;[HDAC3, DTX3L, BAG3, TPR, EIF2AK3, ECT2, TMEM173, GTSE1]
GO:1902480;protein localization to mitotic spindle;8.0;0.9326813400603323;0.8413406700301662;9.533214072687796;35.99248463016168;9.777073627680469;0.0012046360694383546;0.875;[FAM83D]
GO:0006493;protein O-linked glycosylation;8.0;0.7140352122741334;0.7320176061370667;9.022388448921806;176.5615275388073;5.085725745451326;0.005909355431665436;0.6350842511328143;[GALNT12, DPM3, SDF2L1, SLC35C2, PGM3, TRAK1, GALNT10]
GO:0060271;cilium assembly;6.0;0.8653626801206646;0.7558016526504768;9.405380701177911;137.68250629835126;4.347727998726029;0.00460810957959482;0.5454633246350222;[BBS2, SPAG16, ACTR2, ONECUT2, IFT122, FNBP1L, WDR34, DYNLL2, RFX4, CENPJ, TMEM107, CCDC65, SNAP29, CLUAP1]
GO:0031670;cellular response to nutrient;6.0;0.6162540371078848;0.6312473311440869;8.506381466413817;111.40291525692865;5.845247994956144;0.003728555317534849;0.6220465668840318;[SFRP1, XBP1, P2RX4, USF2, HSP90B1]
GO:1904668;positive regulation of ubiquitin protein ligase activity;12.0;1.0;0.9481203125901445;9.628524252492122;754.3373369627636;7.212124270218933;0.025246991808615726;0.8169486831672182;[MASTL]
GO:0007224;smoothened signaling pathway;6.0;0.7763722522362496;0.7113064387082693;8.866384200445225;26.50247477320489;5.528578385631111;8.87013979980389E-4;0.6058520683365068;[CENPJ, IFT122, PKD2L1]
GO:1905515;non-motile cilium assembly;7.0;1.0;0.8509193652572005;9.628524252492122;138.7811185870196;6.039404009397101;0.004644879144209681;0.6597747671587765;[BBS2, CENPJ, TMEM107, IFT122]
GO:1904667;negative regulation of ubiquitin protein ligase activity;12.0;1.0;0.9481203125901445;9.628524252492122;755.449957599424;7.57984905034425;0.025284230220031186;0.835754145523778;[RPS7, FBXO5, MAD2L1]
GO:0006259;DNA metabolic process;6.0;0.44800904580126355;0.5471248354907763;7.116218628516007;145.2579376122707;3.086231350261906;0.004861652448226147;0.4809503273669734;[USP36, FEN1, BTG2, SMG1, WDR48, DCLRE1C, CCNH, CIB1, MCM10, BRCA1, SMG5, YY1, POLB, NIPBL, ALKBH5, CHAF1B, CHAF1A, EXO1, EP300, TOPBP1, NUDT15, ZNF365, UPF1, HELLS, AQR, TIPIN, DFFA, RFC3, RFC4, FBXO18, DTX3L, NCOA6, PARP2, NSMCE2, RAD23A, WRNIP1, TFIP11, BAZ1A, NME1, DDB1, NEIL3, RAD51C, CCNE2, MSH3, CCNE1, TIMELESS, MCM6, KPNB1, MCM2, HDAC1, PNKP, COPS7A, RLF, RAD51AP1, TFPT, POLR2B, RAD21, RAD54L, POLR2G, USP51, ASCC3, EXOSC3, MTA2, FANCI, POLQ, RRM1, APOBEC3F, UBE2B, APOBEC3H, EYA2, XRCC5, INTS3, NONO, GINS3, GINS4, DONSON, APEX2, CDC7, GTF2H4, SETX, CDK9, POLE4, SMUG1, CENPF, HIST3H2A, COPS5, RAD51, NPLOC4, NFIB, NFIC, UBE2T, POLE2, CDK2, CDK2AP1, ERCC5, EZH2]
GO:0010629;negative regulation of gene expression;6.0;0.471430776349301;0.558835700764795;6.738152494595957;59.04642522059629;2.349334787147576;0.001976230713800692;0.44326540286011196;[RPL3, RNH1, NAB1, GFI1, GMNN, EIF4A3, ARID4A, CASC3, IKZF1, IKZF2, UBE2Z, YY1, RPS15, EIF4ENIF1, SAP130, DPF2, TRIM24, WWC3, EP300, SOX8, DIP2A, ZNF564, TLE4, RPS9, IGFBP5, RPS7, ZNF282, SLC35C2, ZBTB32, SND1, RUNX2, ERN1, OLFM1, EID1, ILF3, SFRP1, BRMS1, ZNF93, XRN1, TBL1XR1, PSPC1, CCNE1, HOXB4, TIMELESS, ADNP, RPL29, PPID, MAX, FOXG1, SUPT6H, GLG1, MTDH, FXR1, CCNB1, NLRP7, BAG3, TPR, HIVEP1, HESX1, SUDS3, A2M, BBS2, TFAP2A, DR1, CREBBP, UBE2I, XRCC5, WFS1, NONO, H3F3A, EIF2AK3, CNOT10, LSM5, NFKB1, CDK9, CNOT4, CNOT6, PAN3, CDK5, CNOT1, PKIA, CAPRIN1, SP3, BCL3, CNOT3, CDK2, ZNF658, NFE2L3, SKIV2L, CNOT8, DCP1A, EZH2, CPEB4, PHF19, CDKN1C, USP36, HBS1L, CIITA, BTG2, CDKN1A, SMG1, YWHAB, OTUD7B, PTPN22, BRCA1, SMG5, FLCN, NIPBL, C1QBP, LRRFIP1, HIF1AN, CIC, DACT1, HAVCR2, UPF2, ZNF485, UPF1, TSC22D4, HELLS, KLF12, PEG3, ARID1A, SIRT2, NME1, DUSP22, NCOR1, TFDP2, PTRH2, MTF2, LCOR, ETF1, EIF4E2, DCP2, HDAC3, ZNF350, HDAC1, NLRC4, LRP8, THBS1, RELA, ARNTL, PPP2CA, BCLAF1, RXRA, U2AF2, TP53INP1, POLR2G, EXOSC3, MTA2, E2F7, ZNF189, RPL19, E2F8, IRX1, RNF20, YTHDF3, NFYC, RPL23A, PER2, CENPF, GFI1B, HIST3H2A, NFIB, NFIC, TAF7, LIMS1]
GO:0051574;positive regulation of histone H3-K9 methylation;11.0;0.8933024483968273;0.8790801765280758;9.571365838652174;804.3299673530898;7.474488534686424;0.02692020015733362;0.8146746435927894;[BRCA1]
GO:0032515;negative regulation of phosphoprotein phosphatase activity;10.0;0.8653626801206646;0.8479223519212526;9.5525383455142;1090.4524045737035;5.788089581116195;0.03649646063763195;0.7112441822128948;[PPP1R11, ROCK2, PPME1, PHACTR2, NCKAP1L, MASTL]
GO:0007219;Notch signaling pathway;6.0;0.7763722522362496;0.7113064387082693;8.866384200445225;26.50247477320489;4.99795013456894;8.87013979980389E-4;0.5787157149004503;[ITCH, CREBBP, MAML1, PERP, NOTCH2NL, EP300, DTX2]
GO:0051572;negative regulation of histone H3-K4 methylation;11.0;0.9326813400603323;0.8987696223598284;9.59953671561887;804.8473500351352;8.390779266560578;0.026937516490087493;0.8615337942327104;[BRCA1]
GO:0051573;negative regulation of histone H3-K9 methylation;11.0;0.8933024483968273;0.8790801765280758;9.571365838652174;805.1350321075869;7.57984905034425;0.026947144950155395;0.8200627852632958;[BRCA1]
GO:0010628;positive regulation of gene expression;6.0;0.4705935272257725;0.5584170762030307;6.666693530613812;58.797024432214236;2.2471302570788807;0.001967883493859682;0.43803865843940215;[CRTC2, NCF1, MAML1, CCNH, GFI1, CD80, EIF4A3, ARID4A, RORA, IKZF1, GPATCH3, IKZF2, ELK1, YY1, RPS6KA4, ZXDC, DPF2, TRIM24, EP300, SOX8, IER5, ZNF564, IER2, RPS9, RPS7, FLT3LG, PRKAB1, MED6, RUNX2, PIAS2, ERN1, ARMCX3, OLFM1, ILF3, SFRP1, KARS, IL23A, TBL1XR1, CCNE1, RFX4, HOXB4, MAX, RLF, SUPT6H, C3, FXR1, CCNB1, RAD21, HLTF, DVL3, SCAP, NLRP3, HOXC4, RIPK1, CYTL1, TFAP2A, ZBTB17, ZNF143, DR1, CREBBP, XBP1, RHBDD1, PBX3, EIF2AK3, EAF2, ERLIN2, FLI1, NFKB1, SETX, CDK9, NFKBIA, IL6, STAG1, TFCP2, COPS5, SP1, SP3, MAFF, BCL3, CDK2, NFE2L3, NFE2L1, PHF19, CDKN1C, CIITA, SETD3, ONECUT2, ELL, PTPN22, DDX41, HOXC13, BRCA1, AATF, CKS1B, FLCN, NIPBL, LBH, C1QBP, NUP62, TMED2, CTSH, ZNF485, SEC13, TBP, KLF13, PEG3, DTX3L, NCOA6, ITGA2, MKL1, ARNT, SENP2, SAFB, TMEM173, PPRC1, ARID1A, SIRT2, CREB3, GAL, NCOR1, TFDP2, ELF4, IRF4, MTF2, TFEC, POLR1E, HDAC3, ZNF350, HDAC1, WBP2, ROCK2, POLDIP3, THBS1, RELA, ARNTL, SERTAD3, BCLAF1, CLEC3B, RXRA, U2AF2, SERTAD2, TP53INP2, CCL5, TP53INP1, LMNA, TAF1A, POLR2G, GPBP1L1, MTA2, E2F7, E2F8, TBX1, RNF20, ZNF462, CHURC1, YTHDF3, NFYC, ATAD2, ARID3B, DEK, GRHL1, USF2, CD4, NFIB, TNIP2, NFIC, CAMK4, MARS, PSMC1, TAF7, KRAS, CAMK1, FAM98A, RAB3GAP1, LIMS1]
GO:0010506;regulation of autophagy;6.0;0.6260725219892441;0.6361565735847665;8.273978589686811;43.35793677134884;4.08334148887777;0.001451151124127319;0.5319425862261522;[BECN1, USP36, XBP1, CALCOCO2, ATPIF1, CLEC16A, PTPN22, VPS26B, SIRT2, RASIP1, MTDH, ERN1, FLCN, HERC1, CDK5, TP53INP2, TP53INP1, EP300, CHMP4B, RAB3GAP2, EIF4G2, RAB3GAP1, EXOC1]
GO:0051571;positive regulation of histone H3-K4 methylation;11.0;0.9326813400603323;0.8987696223598284;9.59953671561887;804.0422852806381;7.004484905440688;0.026910571697265715;0.7906386361357586;[BRCA1]
GO:0032873;negative regulation of stress-activated MAPK cascade;11.0;0.8436909121759173;0.8542744084176208;9.56534535087059;1526.0559120613332;6.039404009397101;0.051075718015538125;0.7412843542312382;[ITCH, SFRP1, HDAC3, NCOR1, AMBP, PBK, PTPN22, PAFAH1B1, DACT1]
GO:0001916;positive regulation of T cell mediated cytotoxicity;9.0;0.8653626801206646;0.8289219652406215;9.523163736834295;365.14378084230765;6.518977089658987;0.012221033736724321;0.7296214167088868;[IL23A, IL12A, HLA-A, HLA-F]
GO:0019433;triglyceride catabolic process;8.0;1.0;0.875;9.628524252492122;492.4915826757067;6.518977089658987;0.01648325005850736;0.7083807915285978;[FABP5, MGLL]
GO:0018105;peptidyl-serine phosphorylation;9.0;0.7369933605727446;0.7647373054666613;9.207310787415818;338.73676479787366;4.61801832846594;0.011337214674488616;0.6324062972578516;[SMG1, MAST3, ROCK2, EIF2AK3, CDC7, VRK2, MASTL, CLK1, ERN1, RPS6KA4, CCNB1, CDK5, CAMK4, STK38, MKNK2, CDK2, STK38L, RIPK1, CAMK1, MARK2, CSNK1G2, CSNK1G1]
GO:0030335;positive regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.22453031427283;157.26390226612122;3.6656062881777913;0.005263481280523835;0.5383786413027378;[CD151, ONECUT2, ROCK2, DOCK8, ITGB3, CIB1, CD99L2, THBS1, CORO1A, IGF1R, NIPBL, C1QBP, CCL5, CTSH, NCKAP1L, IL12A, CCL19, ATP7A, GTSE1, CLASP1, CCR2, SEMA6B, PDGFRB, MAP3K3, XBP1, IGFBP5, CCL20, ITGA2, SPHK1, RAB11A, PTP4A1, VIL1, CREB3, IL6, P2RX4, KARS, SP1, IL23A, RUFY3, EPHA1, MAPRE1, TRIM32, HBEGF]
GO:0043967;histone H4 acetylation;12.0;0.8259837884571596;0.8611122068187244;9.464221201200845;659.4528027923784;5.825829909099042;0.022071291840469662;0.7460535250702665;[IRF4, EP300]
GO:0043966;histone H3 acetylation;12.0;0.7671156992804218;0.8316781622303555;9.3498108500231;659.4528027923784;5.926926025970411;0.022071291840469662;0.7512235851885185;[POLE4, DR1, CRTC2, IRF4]
GO:1902255;positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator;10.0;0.8933024483968273;0.861892236059334;9.56183287799345;996.3822919229762;8.390779266560578;0.03334801862481705;0.8443458537639685;[RPS7]
GO:0044818;mitotic G2/M transition checkpoint;10.0;0.8933024483968273;0.861892236059334;9.551563211355994;492.819650181817;6.343086423195323;0.016494230182695288;0.7396267465268138;[FANCI, TAOK2, DONSON, TOPBP1, BRCA1]
GO:0000915;actomyosin contractile ring assembly;8.0;0.9326813400603323;0.8413406700301662;9.567899630675686;135.1741411845403;7.9853141584524145;0.004524156856617609;0.7833693374183408;[PDCD6IP, KIF23]
GO:0051591;response to cAMP;6.0;0.8933024483968273;0.7697715367885581;9.446202695698167;79.54904468548885;5.192106149009898;0.0026624349361310785;0.5886448625081389;[RAP1B, IGFBP5, ITPR2, SDC1, RELA, NME1]
GO:0006465;signal peptide processing;7.0;0.9326813400603323;0.8172600352873667;9.574457031221845;245.95175762031633;7.004484905440688;0.008231783985340883;0.7091290490632969;[SPCS2, SEC11A, SEC11C]
GO:0006468;protein phosphorylation;7.0;0.5708408884191841;0.6363398094667926;8.175090588534603;177.75756772840523;2.970244267288293;0.005949385820444992;0.5028177952168079;[OXTR, SMG1, MAST3, MAML1, CCNH, YWHAB, IL5RA, BUB1B, STK19, IGF1R, RPS6KA4, AKAP13, ZMYM2, RPS6KA2, CFL1, TRIM24, PBK, CTSH, PDGFRB, DUSP5, CSNK2A1, KSR1, CAD, VRK2, OXSR1, MASTL, GFRA2, SPTB, PRKAB1, CIT, ERN1, BCR, GAK, ITPKB, ILF3, KARS, PDIK1L, CCNE1, FASTKD5, PIK3C3, EPHA1, CSNK1G2, HBEGF, CSNK1G1, ROCK2, PKMYT1, RASGRP4, STK3, NUAK1, CCNB1, PABPN1, STK35, CCL5, STK38, MKNK2, STK38L, NCAM1, MBP, RIPK1, CSK, MARK2, MAP3K3, EIF2AK3, CDC7, ERLIN2, CLK4, GTF2H4, CLK3, NFKB1, SETX, CLK1, CDK9, SNRK, PAN3, CDK5, PTPRA, FES, TNIP2, CAMK4, TAOK2, CDK2, CCM2, KRAS, CAMK1, CALM1]
GO:0006103;2-oxoglutarate metabolic process;7.0;0.7980440201809971;0.7499413753476991;9.136047767394327;69.92434603764816;6.832634648514029;0.0023403049340542706;0.7003406189322132;[MRPS36, GPT2, IDH2]
GO:0006346;methylation-dependent chromatin silencing;12.0;1.0;0.9481203125901445;9.628524252492122;1936.9706715625437;7.212124270218933;0.06482866521676948;0.8169486831672182;[HELLS, HDAC1]
GO:0030206;chondroitin sulfate biosynthetic process;8.0;1.0;0.875;9.628524252492122;416.1007025877491;6.558197802812269;0.013926516049292044;0.7103865406232063;[CHPF]
GO:0032869;cellular response to insulin stimulus;8.0;1.0;0.875;9.628524252492122;462.69925393661634;5.334422371190153;0.015486127626965131;0.6478026081386739;[ERRFI1, XBP1, SP1, MARS, RAB13, RAB8B]
GO:0051103;DNA ligation involved in DNA repair;8.0;0.9326813400603323;0.8413406700301662;9.571365838652174;150.14073953485922;7.292166977892469;0.005025075434338753;0.747921758369865;[POLB, PARP2]
GO:0051225;spindle assembly;7.0;0.7508913569872202;0.7263650437508107;9.168991923113682;86.84099814437;5.266214121163619;0.00290649005606778;0.6202338003175094;[HDAC3, NCOR1, TUBGCP2, ZNF207, FBXO5, MAPRE1, TUBG1, KPNB1, CLASP1, RAB11A]
GO:0010832;negative regulation of myotube differentiation;8.0;0.8436909121759173;0.7968454560879586;9.446202695698167;178.40051173448938;6.943860283624253;0.00597090457771659;0.7301093378270707;[XBP1]
GO:0032981;mitochondrial respiratory chain complex I assembly;7.0;1.0;0.8509193652572005;9.628524252492122;91.11357555959822;5.618190544320798;0.003049489377085438;0.638233890966345;[NDUFA7, NDUFB7, NDUFA11, NDUFB10, NDUFS7, NDUFS6, NUBPL, NDUFA10, FOXRED1]
GO:0042769;DNA damage response, detection of DNA damage;5.0;0.7866048967936545;0.6835434602577475;9.143016436710422;39.83823472227698;6.139487467954083;0.0013333498640710748;0.6042146864874571;[DDB1, RFC3, WDR48, RFC4, UBE2B, PNKP]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[CCNH, GFI1, IKZF1, GPATCH3, IKZF2, ELK1, UBE2L3, SAP130, ZXDC, DPF2, TRIM24, SOX8, IER5, IER2, SAP30BP, CSNK2A1, ZNF282, SND1, EID1, EWSR1, RFX4, HOXB4, ZNF276, ZNF395, ZNF394, FOXG1, ZNF20, CDCA7, RPAP1, ZNF25, RAD21, HLTF, HIVEP1, HESX1, HOXC4, HIVEP2, ZNF264, ZNF143, XBP1, SETDB1, ZNF260, XRCC5, INTS3, PBX3, EAF2, FLI1, SOX30, STAG1, ZNF30, INTS4, EZH2, PHF3, SETD5, BTG2, SETD3, ELL, INTS10, ATF7IP2, HOXC13, BRCA1, NIPBL, CHAF1B, ZMYM2, SCML1, C1QBP, CIC, ZNF485, TSC22D4, HELLS, COMMD3, BAZ1A, PPRC1, ZFX, MED29, SIRT2, MED28, NCOR1, TFEC, MED20, VGLL4, ZNF350, ZNF69, RELA, ARNTL, SERTAD3, BCLAF1, SERTAD2, GPBP1L1, ZNF462, NFYC, ATAD2, GRHL1, GTF2H4, PER2, GFI1B, NFIB, NFIC, MARS, ZNF696, CRTC2, NAB1, ARID4A, YY1, EP300, ZNF326, ZNF688, ZNF564, GTF2I, TLE4, ZNF441, ZBTB32, PIAS2, ERN1, ILF3, BRMS1, ZNF93, TBL1XR1, PSPC1, TIMELESS, ADNP, ZNF550, MAX, RLF, SUPT6H, GTF2E2, ZNF549, ZNF548, NLRP3, SUDS3, ZNF544, TRAPPC2, TFAP2A, ZBTB17, DR1, NONO, CNOT10, NFKB1, CDK9, CNOT6, IRAK1BP1, TFCP2, COPS5, CNOT1, SP1, SP3, MAFF, BCL3, CNOT3, ZNF658, NFE2L3, CNOT8, TMEM18, ZNF532, ZNF410, NFE2L1, PHF19, CIITA, ONECUT2, CHD1, AFF4, LBH, ZNF407, NUP62, ZNF768, ZNF525, ZNF524, LRRFIP1, HIF1AN, KLF12, TBP, KLF13, BUD31, MKL1, ARNT, SAFB, ARID1A, CREB3, ZNF519, TFDP2, ELF4, IRF4, LCOR, ZNF630, ITGB3BP, GTF3C1, SMARCD2, HDAC3, HDAC1, WBP2, TFPT, POLR2B, RBBP5, TP53INP2, FAM120B, TP53INP1, TAF1A, POLR2G, ASCC3, E2F7, ZNF189, E2F8, TBX1, POLR2J3, CHURC1, EYA2, ARID3B, DEK, USF2, POLR3C, TNIP2, POLR3E, TAF7, MNDA]
GO:0060052;neurofilament cytoskeleton organization;6.0;1.0;0.8231203125901445;9.628524252492122;29.32696193356961;7.8311634786251565;9.815470233643841E-4;0.7236063770733796;[VPS54, NEFH]
GO:1903233;regulation of calcium ion-dependent exocytosis of neurotransmitter;11.0;0.8933024483968273;0.8790801765280758;9.551563211355994;263.2112308779144;9.083926447120524;0.008809443022755213;0.8969813732811862;[ATP2A2, RAB3GAP1]
GO:0008652;cellular amino acid biosynthetic process;7.0;0.5434879515166714;0.6226633410155362;8.113397019529263;297.30444561691337;5.358233019883872;0.009950512238168282;0.6249396510773795;[MTHFD1, PSAT1, GPT2, MTHFD2L, CAD, SERINC3, GLS]
GO:0006479;protein methylation;8.0;0.5860072649471136;0.6680036324735568;8.391761625343195;206.79845698774034;4.917261223318797;0.006921358248851439;0.6264689676365554;[RAB3B, BTG2, SETD3, SETDB1, ARID4A, RLF, RBBP5, IRF4, ETF1, FAM98A, RAB6A, PCMTD1, EZH2]
GO:0006359;regulation of transcription by RNA polymerase III;10.0;0.8436909121759173;0.837086467948879;9.52844079393514;248.56913769389934;6.481236761676141;0.008319385340914571;0.7466917612613706;[GTF3C1, ZNF143, TBP, ELL, POLR3C, BRCA1]
GO:0006349;regulation of gene expression by genetic imprinting;7.0;0.8933024483968273;0.7975705894556142;9.577230958104572;130.9317736178294;6.8867018697843045;0.004382168632042727;0.7031056191423581;[ARID4A, BRCA1]
GO:0006228;UTP biosynthetic process;11.0;1.0;0.9324289523296623;9.628524252492122;8934.402720436805;7.474488534686424;0.29902641861260104;0.8146746435927894;[CAD, NME1]
GO:0030433;ubiquitin-dependent ERAD pathway;10.0;0.9326813400603323;0.8815816818910864;9.600353375525426;603.0491029665483;5.557565922504363;0.02018351076733335;0.6994551915910392;[SEC13, WFS1, EDEM1, DERL3, SYVN1, DERL2, ERLIN2, HSP90B1, RNF103, NPLOC4, PSMC1, UBQLN1, MAN1B1]
GO:0006281;DNA repair;7.0;0.6281612110245125;0.6649999707694567;8.781226392104918;180.342582143442;3.582668236575797;0.006035903926554339;0.534137185486798;[USP36, FEN1, BTG2, SMG1, WDR48, DCLRE1C, CCNH, CIB1, BRCA1, YY1, POLB, NIPBL, CHAF1B, CHAF1A, EXO1, EP300, TOPBP1, UPF1, AQR, RFC3, RFC4, FBXO18, DTX3L, NCOA6, PARP2, NSMCE2, RAD23A, DDB1, NEIL3, RAD51C, MSH3, TIMELESS, PNKP, COPS7A, RAD51AP1, TFPT, POLR2B, RAD21, RAD54L, POLR2G, USP51, FANCI, POLQ, UBE2B, EYA2, XRCC5, INTS3, NONO, GINS4, APEX2, CDC7, GTF2H4, SETX, CDK9, SMUG1, HIST3H2A, COPS5, RAD51, NPLOC4, UBE2T, POLE2, CDK2, ERCC5]
GO:0006284;base-excision repair;8.0;0.9326813400603323;0.8413406700301662;9.584072489921288;183.0506323445446;5.69953618377475;0.006126539929698291;0.6664745454937787;[POLB, SMUG1, USP36, POLQ, NEIL3, PARP2, APEX2]
GO:0030031;cell projection assembly;4.0;0.6729672293956388;0.5864836146978194;8.124446855715847;35.515967283127445;3.9749552523034066;0.0011886874626708887;0.45327939645711923;[BBS2, SPAG16, NCKAP1, ACTR2, ONECUT2, IFT122, EMP3, FNBP1L, WDR34, DYNLL2, PARVG, RFX4, CENPJ, TMEM107, CCDC65, NCKAP1L, FXYD5, SNAP29, CLUAP1, NEFH]
GO:0006283;transcription-coupled nucleotide-excision repair;9.0;1.0;0.896240625180289;9.628524252492122;184.43692670566384;5.486614186532078;0.006172937954381027;0.676826329833192;[DDB1, AQR, RFC3, COPS5, RFC4, POLR2B, CCNH, EP300, POLR2G, COPS7A, ERCC5, GTF2H4]
GO:0006165;nucleoside diphosphate phosphorylation;9.0;0.6799073451904818;0.73619429777553;8.98189708756707;372.83427223459927;5.734022359845919;0.012478427562631417;0.6894787953221185;[HK3, TPI1, ADPGK, BPGM, ALDOA, NME1]
GO:0000733;DNA strand renaturation;7.0;0.9326813400603323;0.8172600352873667;9.584072489921288;172.76820112826425;7.57984905034425;0.005782396210476689;0.738553198190834;[RAD54L, WRNIP1]
GO:0045766;positive regulation of angiogenesis;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;134.49314513679974;4.7081694254602375;0.0045013645317563845;0.5916953686275062;[MAP3K3, XBP1, SPHK1, ITGB2, CIB1, BRCA1, THBS1, MTDH, C3, RRAS, SP1, TBXA2R, CTSH, EPHA1]
GO:0006048;UDP-N-acetylglucosamine biosynthetic process;8.0;0.9326813400603323;0.8413406700301662;9.59573442966913;711.6265136604915;7.379178354882098;0.02381749898993409;0.7523715242355574;[PGM3]
GO:0045404;positive regulation of interleukin-4 biosynthetic process;8.0;1.0;0.875;9.628524252492122;833.6113263844036;9.083926447120524;0.027900220892599446;0.839552420951524;[IRF4]
GO:0045892;negative regulation of transcription, DNA-templated;10.0;0.556709148698489;0.6935955862101648;8.520155788878647;1581.2569993850602;2.683669001811703;0.05292324873051003;0.5524839694169422;[NAB1, GFI1, GMNN, ARID4A, IKZF1, IKZF2, YY1, SAP130, DPF2, TRIM24, WWC3, EP300, SOX8, ZNF564, TLE4, ZNF282, ZBTB32, RUNX2, EID1, ILF3, SFRP1, BRMS1, ZNF93, TBL1XR1, PSPC1, CCNE1, HOXB4, TIMELESS, PPID, MAX, FOXG1, SUPT6H, MTDH, BAG3, TPR, HIVEP1, HESX1, SUDS3, TFAP2A, DR1, CREBBP, UBE2I, XRCC5, WFS1, NONO, H3F3A, NFKB1, CDK5, CNOT1, PKIA, SP3, BCL3, CDK2, ZNF658, NFE2L3, EZH2, CDKN1C, USP36, CIITA, BTG2, YWHAB, OTUD7B, BRCA1, FLCN, NIPBL, C1QBP, LRRFIP1, HIF1AN, CIC, DACT1, ZNF485, TSC22D4, HELLS, KLF12, PEG3, ARID1A, SIRT2, DUSP22, NCOR1, TFDP2, MTF2, LCOR, HDAC3, ZNF350, HDAC1, LRP8, RELA, ARNTL, BCLAF1, RXRA, MTA2, E2F7, ZNF189, E2F8, IRX1, NFYC, PER2, CENPF, GFI1B, HIST3H2A, NFIB, NFIC, TAF7, LIMS1]
GO:0045893;positive regulation of transcription, DNA-templated;10.0;0.5159906454948852;0.673236334608363;8.141425192250265;1208.1179641469014;2.4745772039531437;0.04043462102441837;0.5417910051506925;[CRTC2, NCF1, MAML1, CCNH, GFI1, CD80, ARID4A, RORA, IKZF1, GPATCH3, IKZF2, ELK1, YY1, RPS6KA4, ZXDC, DPF2, TRIM24, EP300, SOX8, IER5, ZNF564, IER2, FLT3LG, MED6, RUNX2, PIAS2, ARMCX3, ILF3, SFRP1, KARS, IL23A, TBL1XR1, CCNE1, RFX4, HOXB4, MAX, RLF, SUPT6H, RAD21, HLTF, DVL3, SCAP, NLRP3, HOXC4, RIPK1, CYTL1, TFAP2A, ZBTB17, ZNF143, DR1, CREBBP, XBP1, PBX3, EIF2AK3, EAF2, ERLIN2, FLI1, NFKB1, SETX, CDK9, NFKBIA, IL6, STAG1, TFCP2, COPS5, SP1, SP3, MAFF, BCL3, CDK2, NFE2L3, NFE2L1, PHF19, CDKN1C, CIITA, SETD3, ONECUT2, ELL, DDX41, HOXC13, BRCA1, AATF, CKS1B, FLCN, NIPBL, LBH, NUP62, ZNF485, SEC13, TBP, KLF13, PEG3, DTX3L, NCOA6, MKL1, ARNT, SENP2, SAFB, TMEM173, PPRC1, ARID1A, SIRT2, CREB3, GAL, TFDP2, ELF4, IRF4, MTF2, TFEC, HDAC3, ZNF350, HDAC1, WBP2, RELA, ARNTL, SERTAD3, BCLAF1, RXRA, SERTAD2, TP53INP2, TP53INP1, GPBP1L1, MTA2, E2F7, E2F8, TBX1, RNF20, ZNF462, CHURC1, NFYC, ATAD2, ARID3B, GRHL1, USF2, CD4, NFIB, TNIP2, NFIC, CAMK4, MARS, PSMC1, TAF7, CAMK1]
GO:0032201;telomere maintenance via semi-conservative replication;8.0;0.8933024483968273;0.8216512241984136;9.55953138100517;216.32599304453976;6.7325511899570465;0.0072402363064467505;0.719302980950052;[UPF1, FEN1, RFC3, RFC4]
GO:0018279;protein N-linked glycosylation via asparagine;9.0;0.8653626801206646;0.8289219652406215;9.4949928598676;334.83267440717236;6.113511981550823;0.011206548282565083;0.7088859122241795;[DERL3, RPN1, SYVN1, STT3A]
GO:0035711;T-helper 1 cell activation;8.0;1.0;0.875;9.628524252492122;24.976814605194843;9.083926447120524;8.359515071621009E-4;0.839552420951524;[IL12A]
GO:0071805;potassium ion transmembrane transport;9.0;0.8259837884571596;0.8092325194088689;9.456673995565463;120.6235085317852;4.695669262696007;0.004037160276449102;0.636377369645515;[KCNK6, KCND1, SLC9A6, KCNK12, PKD2L1, KCNK3]
GO:0065003;protein-containing complex assembly;4.0;0.45485133202666184;0.4774256660133309;6.058991556010752;36.471478728154885;2.4440506132939883;0.0012206675708314864;0.3749888620238313;[CRTC2, RPL3, DGKD, NDUFA11, NCF1, CCNH, NDUFA10, GMNN, PKD2L1, IKZF1, TMEM141, IPO4, GLS, IGF1R, PSMD8, RPS15, PSMD4, TFG, ZNF207, EP300, OIP5, KNTC1, FBXO5, TLE4, COG4, PRKAB1, KCTD5, MED6, COX7A2L, TBC1D20, KCTD10, PRPF3, SNRPG, KCTD14, CHMP4B, CD2BP2, TSPYL6, PPID, HIST1H2BC, NDUFB10, TUBGCP2, YTHDC1, EPB41, MAX, KLHL12, ATXN2, CCNB1, SPAST, RNF213, TSPAN4, NLRP3, NCKAP1L, RIPK1, ECT2, TRAPPC2, VASP, TRAPPC3, CREBBP, CPSF6, TOR1A, H3F3A, EIF2AK3, NUP153, PILRB, RPL3L, SETX, VIL1, COL1A2, SYNJ1, ARPC2, AHCTF1, GPAA1, YWHAB, SRP54, CLTA, USP39, CLYBL, PPP6C, CHAF1B, CHAF1A, C1QBP, NUP62, TMED2, SNAP29, RBM5, ATPAF2, FGA, SEC13, PDCD6IP, TBP, KCND1, FCER1G, ATPIF1, FGG, CKAP5, TAPBP, DDB1, ALDH5A1, RAD51C, NDUFS7, TRAPPC6B, NDUFS6, POLR1E, VAMP4, CHMP6, ALDOA, SLU7, ITGB3BP, MCM2, COLEC12, NDUFB7, HIST1H2BO, HIST1H2BJ, HDAC1, DDX23, NLRC4, HSD17B8, TM9SF4, NAPG, FOXRED1, HLA-DMA, RXRA, HLA-DMB, RBBP5, CCL5, UBN1, AP2S1, STX5, BID, POLQ, RRM1, NDUFA7, NUBPL, RPL23A, GTF2H4, CENPE, CENPF, MARCKS, RAD51, P2RX4, CENPH, IMPDH2, CENPJ, CENPK, TAF7, CCDC65, ERCC5, CENPP, SEC24C]
GO:0007264;small GTPase mediated signal transduction;6.0;0.7369933605727446;0.6916169928765168;8.741221057491218;26.42836680105094;4.015022244900292;8.845336528452411E-4;0.5284487369119741;[RAB3B, BCAR3, NCKAP1, CDKN1A, ROCK2, DOCK8, RASGRP2, RASGRP4, RAB21, RAB43, RAP1B, ABR, DOCK11, RHOT2, RHOT1, RAB20, RRAS, ARHGDIB, CFL1, RAB28, RAB6A, RAB8B, KSR1, SETDB1, RAB27B, VAV1, RAB11A, NISCH, COL1A2, ALS2, RAB13, CDK2, RAB18, ELMO1, TAX1BP3, KRAS, ARHGEF1, DOCK2, RGL1, KPNB1]
GO:0006296;nucleotide-excision repair, DNA incision, 5'-to lesion;8.0;1.0;0.875;9.628524252492122;115.13879119899096;6.166155715036245;0.0038535917232456105;0.6903374900225189;[DDB1, RFC3, RFC4, ERCC5, GTF2H4]
GO:0007020;microtubule nucleation;6.0;0.7980440201809971;0.722142322680643;9.0689084645567;33.1981629444775;6.686031174322154;0.0011111126373447525;0.665044257777226;[NIN, TUBGCP2, CENPJ, TUBG1, CLASP1]
GO:0007147;female meiosis II;8.0;1.0;0.875;9.628524252492122;138.0508710385328;9.083926447120524;0.004620438415941954;0.839552420951524;[MASTL]
GO:0007265;Ras protein signal transduction;7.0;0.7586651285174919;0.7302519295159464;8.935377071932177;27.526979089716047;4.2636448815154875;9.213032174599934E-4;0.5689623627776663;[RAB3B, NCKAP1, CDKN1A, ROCK2, RASGRP2, RAB21, RAB43, RAP1B, RHOT2, RHOT1, RAB20, RRAS, ARHGDIB, CFL1, RAB28, RAB6A, RAB8B, KSR1, SETDB1, RAB27B, RAB11A, NISCH, COL1A2, ALS2, RAB13, CDK2, RAB18, ELMO1, TAX1BP3, KRAS, ARHGEF1, KPNB1]
GO:0006297;nucleotide-excision repair, DNA gap filling;7.0;1.0;0.8509193652572005;9.628524252492122;149.0421272461911;6.641579411751319;0.0049883058697239;0.6905700452391912;[RFC3, RFC4]
GO:0042149;cellular response to glucose starvation;7.0;0.8933024483968273;0.7975705894556142;9.503361109538115;115.90251486529202;6.063501560976162;0.003879152867050031;0.6610071170671804;[BECN1, XBP1, TBL2, EIF2AK3, PIK3C3, CPEB4]
GO:0042271;susceptibility to natural killer cell mediated cytotoxicity;10.0;1.0;0.9152410118609203;9.628524252492122;432.4152632790882;7.212124270218933;0.014472549713479789;0.7840693824379941;[CADM1]
GO:0045540;regulation of cholesterol biosynthetic process;9.0;0.8933024483968273;0.8428918493787028;9.4949928598676;116.98845768213258;6.039404009397101;0.0039154983958446;0.705096027081865;[SQLE, SP1, NFYC, SCAP, ELOVL6, ERLIN2, KPNB1]
GO:0018022;peptidyl-lysine methylation;9.0;0.6913464685778243;0.7419138594692012;9.146686165599384;367.0481392324785;5.346256828837156;0.012284770898232059;0.6696484480333891;[SETD3, SETDB1, RBBP5, IRF4, ARID4A, RLF, EZH2]
GO:0001837;epithelial to mesenchymal transition;5.0;0.7508913569872202;0.6656866903545304;8.647694999480395;23.145667324477426;5.618190544320798;7.746646556020492E-4;0.5775555375700647;[OLFM1, KLHL12, FAM83D]
GO:1990418;response to insulin-like growth factor stimulus;5.0;1.0;0.7902410118609202;9.628524252492122;25.223505691001428;8.67846133901236;8.44208035796484E-4;0.7340579283277371;[XBP1]
GO:0034614;cellular response to reactive oxygen species;5.0;0.7671156992804218;0.6737988615011312;9.197741336399668;144.094088465717;5.076593261888053;0.004822699464687224;0.5498582273596049;[SETX, BECN1, IL6, NCF1, PXMP2, CDK2, ECT2, RELA, EZH2]
GO:0034976;response to endoplasmic reticulum stress;4.0;0.6799073451904818;0.5899536725952409;8.284789505791027;28.997869804256865;4.300610075748959;9.705326059599744E-4;0.4699333992726228;[DERL3, DERL2, TXNDC11, ATP2A2, THBS1, BBC3, HSP90B1, EXTL2, LMNA, UBQLN1, ZBTB17, SEC13, XBP1, TOR1A, SDF2L1, WFS1, EDEM1, RHBDD1, SYVN1, EIF2AK3, ERLIN2, ARFGAP1, ERN1, CREB3, TBL2, RNF103, NPLOC4, CTDSP2, PSMC1, DNAJB11, TPP1, HYOU1, MAN1B1]
GO:0032435;negative regulation of proteasomal ubiquitin-dependent protein catabolic process;11.0;0.8436909121759173;0.8542744084176208;9.523163736834295;3784.4609618058316;6.343086423195323;0.1266625025978984;0.7568146869955557;[CLEC16A, PBK]
GO:0043009;chordate embryonic development;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;22.496195207419138;4.623782033182691;7.529274083310655E-4;0.5595807407949613;[ELL, UBE2B, BRCA1, RIC8A, FLCN, CCNB1, RXRA, ALS2, MAFF, CCM2, SOX8, EIF4E2, ATP7A, APBA3, SEC24C]
GO:0006260;DNA replication;7.0;0.7307253602413294;0.7162820453778652;9.271849308553389;254.20053156235352;4.77312732173501;0.008507863025766288;0.5950173184638491;[FEN1, PNKP, MCM10, BRCA1, POLB, CHAF1B, CHAF1A, EXO1, UPF1, POLQ, RRM1, RFC3, RFC4, NCOA6, DONSON, WRNIP1, CDC7, BAZ1A, NFIB, NFIC, POLE2, CDK2, CDK2AP1, MCM6, MCM2]
GO:0006261;DNA-dependent DNA replication;8.0;0.7586651285174919;0.754332564258746;9.318369324188282;254.89367874291247;6.250713103064308;0.008531062038107634;0.6946617587785947;[POLB, POLQ, RFC3, RFC4, POLE2, PNKP, DONSON, CDK2AP1, WRNIP1, BAZ1A]
GO:0097191;extrinsic apoptotic signaling pathway;6.0;0.8259837884571596;0.7361122068187242;9.223059144383958;51.05903939735586;5.277263957350204;0.0017089000984773794;0.5929998367869052;[DIABLO, EYA2, PARP2, CD70, G0S2, CIB1, TNFRSF10A, BAG3, MKNK2, CASP2, RIPK1, IL12A, BID]
GO:0045787;positive regulation of cell cycle;5.0;0.5265193887476639;0.5535007062347522;7.230628979693751;42.184038669436575;3.8238302933926853;0.0014118618110960173;0.4857918708913159;[FEN1, BTG2, CDKN1A, CCNH, CCNF, KIF14, BRCA1, CKS1B, NIPBL, FNTB, NUP62, CASP2, EP300, GTSE1, PDGFRB, SPHK1, NSMCE2, FLT3LG, RAD23A, KIF23, SIRT2, CDC25A, CIT, RAD51C, ESPL1, TFDP2, CCNE2, CCNE1, PKP4, ANAPC5, PAFAH1B1, ANKRD17, BECN1, ROCK2, FOXG1, ANAPC11, CCNB1, SPAST, RAD21, TPR, ECT2, FAM83D, E2F7, E2F8, ZBTB17, UBE2B, CNOT10, CDC7, NDC80, RAB11A, CDK9, CNOT4, NSFL1C, CNOT6, FAP, CNOT1, CNOT3, CDK2, CNOT8, TRIM32, CCNJL, MAD2L1]
GO:0042276;error-prone translesion synthesis;10.0;1.0;0.9152410118609203;9.628524252492122;760.9157207671086;6.7325511899570465;0.025467164394386097;0.7595439928109722;[RFC3, RFC4, POLE2]
GO:0007595;lactation;6.0;1.0;0.8231203125901445;9.628524252492122;25.956233089099676;5.9928839937622085;8.687317623989867E-4;0.6295966787287501;[OXTR, CAD, ATP7A, USF2, NME1]
GO:1901800;positive regulation of proteasomal protein catabolic process;10.0;0.7763722522362496;0.8034271379790452;9.430698509162202;1662.1011242697743;5.104244793218563;0.05562902883541267;0.6762723279577749;[XBP1, ZFAND2A, EDEM1, PSMC1, UBQLN1, RAD23A, SIRT2]
GO:0044458;motile cilium assembly;7.0;1.0;0.8509193652572005;9.628524252492122;138.7811185870196;6.641579411751319;0.004644879144209681;0.6905700452391912;[CENPJ]
GO:0048936;peripheral nervous system neuron axonogenesis;9.0;1.0;0.896240625180289;9.628524252492122;65.99544162831262;9.083926447120524;0.0022088080392582156;0.8607930461318132;[NEFH]
GO:0006268;DNA unwinding involved in DNA replication;8.0;0.8259837884571596;0.7879918942285797;9.34084218004034;24.41922106263308;7.57984905034425;8.172893530941673E-4;0.7626338329336335;[RAD51, MCM6, MCM2]
GO:0019221;cytokine-mediated signaling pathway;6.0;0.6039883530135606;0.6251144890969248;7.604142487995313;26.50247477320489;3.309374901576116;8.87013979980389E-4;0.49236189895841853;[CIITA, CDKN1A, CD80, ITGB2, IL5RA, CIB1, RORA, IL27, RPS6KA4, CFL1, IL12A, CCR2, HLA-DPA1, IFNAR2, IL4R, FLT3LG, HLA-A, HLA-F, YWHAZ, VAV1, KARS, IL23A, IRF4, PSME2, LCP1, EBI3, LRP8, ADIPOR2, RELA, IL22RA2, HSP90B1, RAP1B, CCL5, IL21R, NCAM1, RIPK1, CCL19, HLA-DQA1, BBS2, MAP3K3, CCL20, CD70, TNFRSF10A, NFKB1, NFKBIA, CD4, IL6, COL1A2, TNIP2, HLA-DPB1, SDC1, KRAS, HLA-DRB3, LIMS1]
GO:0043011;myeloid dendritic cell differentiation;6.0;0.8933024483968273;0.7697715367885581;9.4949928598676;91.1712242271392;6.8867018697843045;0.003051418826107602;0.6753065664753021;[IRF4, CAMK4, UBD]
GO:0071712;ER-associated misfolded protein catabolic process;9.0;1.0;0.896240625180289;9.628524252492122;305.4386451462502;7.212124270218933;0.010222756576110884;0.7650689957573628;[TOR1A, SDF2L1]
GO:0070987;error-free translesion synthesis;10.0;1.0;0.9152410118609203;9.628524252492122;760.9157207671086;6.781341354126479;0.025467164394386097;0.7620391240755716;[RFC3, NPLOC4, RFC4]
GO:0006270;DNA replication initiation;7.0;0.7980440201809971;0.7499413753476991;9.405380701177911;149.0421272461911;6.343086423195323;0.0049883058697239;0.6753050999230941;[CCNE2, CCNE1, GINS4, MCM10, CDC7, TOPBP1, MCM6, MCM2]
GO:0000729;DNA double-strand break processing;7.0;0.811012628672052;0.7564256795932265;9.35659053700848;149.0421272461911;6.599019797332524;0.0049883058697239;0.6883935445785896;[EXO1, BRCA1]
GO:0006273;lagging strand elongation;9.0;0.9326813400603323;0.8625812952104552;9.577230958104572;265.91551950056737;7.9853141584524145;0.008899953129253659;0.8046099625986299;[PARP2]
GO:0032781;positive regulation of ATPase activity;6.0;0.7508913569872202;0.6985659910837546;8.781226392104918;51.416896668601964;5.8067817141283475;0.0017208772592953517;0.6200793994936333;[DNAJC7, DNAJB11, DYNLL2]
GO:0031571;mitotic G1 DNA damage checkpoint;11.0;1.0;0.9324289523296623;9.628524252492122;856.0185997856339;7.474488534686424;0.0286501721681018;0.8146746435927894;[CDK2]
GO:0006271;DNA strand elongation involved in DNA replication;8.0;0.7763722522362496;0.7631861261181248;9.417215158824915;149.73527442675106;7.069023426578259;0.005011504882065279;0.7365101867784198;[RFC3, RFC4, PARP2, GINS3, GINS4]
GO:0000724;double-strand break repair via homologous recombination;9.0;0.8653626801206646;0.8289219652406215;9.515195567185119;520.6240308586224;5.299736813202263;0.01742481778162994;0.6672694122704188;[POLQ, FEN1, WDR48, FBXO18, GINS4, NSMCE2, CDC7, BRCA1, YY1, RAD51AP1, NIPBL, RAD51C, RAD51, RAD54L]
GO:0000723;telomere maintenance;7.0;0.7307253602413294;0.7162820453778652;9.292052015870908;183.01793442924338;5.266214121163619;0.006125445559899373;0.6202338003175094;[UPF1, FEN1, RFC3, DCLRE1C, RFC4, XRCC5, NSMCE2, TFIP11, SMG5, RAD51C, RAD51, CCNE2, CCNE1, ZNF365]
GO:0007129;synapsis;6.0;1.0;0.8231203125901445;9.628524252492122;47.18392532465019;6.686031174322154;0.0015792035178401665;0.665044257777226;[CCNE2, CCNE1]
GO:0048704;embryonic skeletal system morphogenesis;5.0;0.8653626801206646;0.7229223519212526;9.377209824211215;45.48774390093071;5.346256828837156;0.0015224338520524504;0.5636488347140203;[TBX1, TFAP2A, EIF4A3, HOXB4, HOXC4, RUNX2]
GO:0046651;lymphocyte proliferation;5.0;0.6873818243518346;0.6339319240368375;8.734706376470026;28.263571572696247;5.500407508664414;9.459563049751445E-4;0.571532107649126;[HELLS, CD151, IL23A, ELF4, DOCK8, IMPDH2, EBI3, DOCK2]
GO:0031204;posttranslational protein targeting to membrane, translocation;10.0;1.0;0.9152410118609203;9.628524252492122;169.63248762716802;8.67846133901236;0.005677446701553932;0.8590579283277371;[HYOU1]
GO:0010882;regulation of cardiac muscle contraction by calcium ion signaling;9.0;0.9326813400603323;0.8625812952104552;9.571365838652174;68.46878113000767;6.641579411751319;0.0022915884865189126;0.7358913051622797;[ATP2A2, CALM3, CALM1, CALM2]
GO:0007050;cell cycle arrest;6.0;0.811012628672052;0.7286266269261705;9.292052015870908;55.61614271062087;4.7664383335842135;0.0018614222452456451;0.5668761906316916;[ERN1, CDKN1C, CDKN1A, CDKN2C, FAP, TP53INP1, IL12A, PRR11, THBS1, PRKAB1, EIF4G2, PPM1G]
GO:0010460;positive regulation of heart rate;8.0;0.7763722522362496;0.7631861261181248;9.249034630787218;94.35920462208708;6.641579411751319;0.003158117660930423;0.7146506799819907;[NPPA, ATP2A2]
GO:0007052;mitotic spindle organization;7.0;0.8259837884571596;0.7639112594857803;9.280217558223907;96.21539173928952;5.486614186532078;0.0032202425732832385;0.6315050699101035;[TUBGCP2, TUBG1, NDC80, RAB11A, CENPE, CCNB1, SPAST, KIF4A, TBCE, NUF2, ZNF207, KPNB1, CLASP1, SPC25]
GO:0045600;positive regulation of fat cell differentiation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;114.26328322821418;5.71663061713405;0.00382428925936973;0.6154690682008903;[SFRP1, XBP1, STK3]
GO:0043666;regulation of phosphoprotein phosphatase activity;9.0;0.7436939687323844;0.7680876095464813;9.328419660041783;158.30216566976694;5.058574756385375;0.005298231022267458;0.6549363734696205;[PDGFRB, PPP1R11, ROCK2, PPP2R5D, MASTL, HSP90B1, NSFL1C, NUAK1, PPME1, PPP1R7, RCAN3, PHACTR2, NCKAP1L, CALM3, CALM1, CALM2]
GO:0031398;positive regulation of protein ubiquitination;10.0;0.7508913569872202;0.7906866903545304;9.372590878354922;528.4459358446122;5.113634533568402;0.01768660990225356;0.6767525197159333;[CDK9, FANCI, RNF20, WFS1, SPHK1, UBQLN1, PTPN22, BRCA1, SENP2, SKP2, MASTL, UBE2L3]
GO:0010216;maintenance of DNA methylation;7.0;1.0;0.8509193652572005;9.628524252492122;149.0421272461911;8.16763571524637;0.0049883058697239;0.7686126355688037;[HELLS]
GO:0033574;response to testosterone;5.0;0.9326813400603323;0.7565816818910864;9.533214072687796;91.03892825708995;6.063501560976162;0.003046990999048697;0.6003287636709002;[XRN1, TBXA2R, ROCK2, CAD, ELK1, THBS1, NME1]
GO:0032006;regulation of TOR signaling;7.0;0.7866048967936545;0.7442218136540277;9.260799472366804;45.070113835906206;5.244474134527214;0.001508456149618737;0.6191220163899107;[FLCN, SEC13, HDAC3, SEH1L, DDIT4, CLEC16A, RFFL, FAM83D, ARNTL]
GO:0010575;positive regulation of vascular endothelial growth factor production;6.0;1.0;0.8231203125901445;9.628524252492122;64.54350789155374;6.481236761676141;0.002160213123744424;0.6545710619905948;[C3, EIF2AK3, ARNT, RORA, BRCA1]
GO:0045739;positive regulation of DNA repair;8.0;0.7671156992804218;0.7585578496402109;9.360260265897443;499.6181899148078;5.8650506222523235;0.01672177118926996;0.6749389615747303;[DTX3L, EYA2, TIMELESS, BRCA1]
GO:0045737;positive regulation of cyclin-dependent protein serine/threonine kinase activity;12.0;0.8933024483968273;0.8947715367885583;9.585964638073326;2922.0785093664276;6.193554689224359;0.09779933800857048;0.7648589874268262;[CCNB1, CCNH, CKS1B]
GO:0046827;positive regulation of protein export from nucleus;9.0;0.811012628672052;0.801746939516315;9.431813958246067;516.7269860224134;6.7325511899570465;0.017294387198074676;0.740543606130341;[BAG3, TPR, CAMK1, GTSE1]
GO:0033693;neurofilament bundle assembly;8.0;1.0;0.875;9.628524252492122;65.53607639725806;8.67846133901236;0.002193433498376687;0.8188169164668168;[NEFH]
GO:1903298;negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;827.8484595660956;8.16763571524637;0.027707342926434095;0.8329342821725234;[HYOU1]
GO:0061087;positive regulation of histone H3-K27 methylation;11.0;0.9326813400603323;0.8987696223598284;9.59953671561887;804.0422852806381;7.9853141584524145;0.026910571697265715;0.8407982897480031;[MTF2, PHF19]
GO:0043433;negative regulation of DNA binding transcription factor activity;11.0;0.811012628672052;0.8379352666656883;9.468181602416943;278.0076986152632;4.753193106834193;0.00930466748196786;0.6755074688592472;[NFKBIA, ITCH, NLRP12, BRMS1, WFS1, ADORA3, GFI1, NLRP3, EZH2, HAVCR2]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[SERPINA3, CSTB, PYGB, PDXK, SIGLEC9, CLEC12A, ITGB2, UBR4, IQGAP2, C3, RAP1B, HK3, PSMD7, PSMD2, PSMB1, LAMP2, CTSH, NCKAP1L, GUSB, RAB6A, SNAP29, ACTR2, SERPINB1, TMEM30A, FCER1G, XRCC5, HSPA6, SURF4, PLAUR, COMMD3, RNASE3, TMEM173, LILRB3, UNC13D, NFKB1, SERPINB6, ACLY, FABP5, IMPDH2, RAB18, PTX3, MNDA, DEGS1, MAN2B1, DOCK2, ALDOA, SLC27A2, KPNB1]
GO:0042102;positive regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;564.8543510249671;5.212725436212633;0.018905166792893686;0.6628196464047262;[TFRC, CD80, EBI3, PDCD1LG2, CORO1A, CD4, IL6, HLA-DMB, IL23A, CCL5, HLA-DPB1, NCKAP1L, IL12A, CCL19, CCR2, HLA-DPA1, HAVCR2]
GO:0097186;amelogenesis;6.0;1.0;0.8231203125901445;9.628524252492122;26.73958370240551;7.474488534686424;8.949498024565515E-4;0.7053660038532718;[ITGB4, PERP]
GO:0001881;receptor recycling;6.0;0.8436909121759173;0.7449657686781032;9.223059144383958;34.80127764040325;7.379178354882098;0.0011647674435078296;0.7004918368257019;[ARFGEF2, CAMLG, ALS2, PLEKHJ1]
GO:0033209;tumor necrosis factor-mediated signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.510741216835738;30.19135422731818;5.395046993006588;0.00101047745553359;0.6268223193749;[NFKBIA, KARS, CD70, RIPK1, TNFRSF10A, RELA, LIMS1]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[CMTM7, ERRFI1, COPA, UBE2I, NCF1, CCL20, CD70, BUD31, EBI3, FLT3LG, IL27, IL6, GAL, CDK5, IL23A, CCL5, NPPA, IL12A, FAM3C, CCL19, CHMP6, KCNK3, HBEGF]
GO:0035744;T-helper 1 cell cytokine production;8.0;1.0;0.875;9.628524252492122;53.326986718937256;8.390779266560578;0.0017848062543106336;0.8041048419030481;[IL12A]
GO:1904153;negative regulation of retrograde protein transport, ER to cytosol;12.0;1.0;0.9481203125901445;9.628524252492122;2754.969419366111;7.57984905034425;0.09220634715467685;0.835754145523778;[DERL3, DERL2]
GO:0007032;endosome organization;5.0;0.8436909121759173;0.712086467948879;9.223059144383958;20.915744831851537;5.528578385631111;7.000311565738116E-4;0.5729727676072827;[VPS18, ARFGEF2, PDCD6IP, ALS2, VTA1, VPS33B, VPS11, CHMP4B, PIK3C3, CHMP6, RAB11A, PLEKHJ1]
GO:0032470;positive regulation of endoplasmic reticulum calcium ion concentration;11.0;0.9326813400603323;0.8987696223598284;9.57973408832269;289.7905246169981;9.083926447120524;0.009699028064390986;0.8969813732811862;[ATP2A2]
GO:0006183;GTP biosynthetic process;11.0;1.0;0.9324289523296623;9.628524252492122;9648.749331526727;7.379178354882098;0.32293495681556944;0.8098004765652196;[IMPDH2, NME1]
GO:0045622;regulation of T-helper cell differentiation;11.0;0.7369933605727446;0.8009256326160346;9.405380701177911;244.89752924133975;6.250713103064308;0.00819649991024048;0.7520907111082569;[IL4R, IL23A, IRF4, CD80, NLRP3, IL27, CCL19]
GO:0043686;co-translational protein modification;7.0;0.9326813400603323;0.8172600352873667;9.56398573135455;151.15475272427284;8.67846133901236;0.005059013543235805;0.7947362817240173;[STT3A]
GO:0043687;post-translational protein modification;7.0;0.6467165523344657;0.6742776414244334;8.507933057105237;151.15475272427284;3.8799197600437285;0.005059013543235805;0.5493386422205575;[ITIH2, PRKCSH, SERPINA10, CCNF, NEDD8, COPS7A, MSLN, PSMB10, PSMA7, HSP90B1, PSMD8, C3, TGOLN2, PSMD7, PSMB5, PSMD4, RBBP5, PSMD2, UBD, PSMB1, SKP2, APOL1, FGA, KLHL25, IGFBP5, WFS1, RHBDD1, FGG, FBXL15, FBXL16, RAB11A, DDB1, IL6, SPSB1, COPS5, PSMA1, PSMC1, RAB13, STT3A, PSME2, FBXL3, ASB3]
GO:2000617;positive regulation of histone H3-K9 acetylation;12.0;1.0;0.9481203125901445;9.628524252492122;1488.212472397538;7.8311634786251565;0.049809132146875434;0.8486063770733797;[BRCA1]
GO:0034765;regulation of ion transmembrane transport;6.0;0.45556283921517005;0.5509017321977295;6.676594601596523;33.03735142972539;3.697140432584879;0.0011057304206669666;0.512192246247148;[KCNK6, CLIC5, AHCYL1, KCND1, WDR1, KCNK12, CACNA2D3, OXSR1, THBS1, CORO1A, CRHR1, PER2, GAL, SLMAP, NPPA, UBQLN1, ARL6IP5, RIPK1, CALM3, FXYD5, ATP7A, CALM1, CALM2, NTSR1]
GO:0034644;cellular response to UV;7.0;0.7980440201809971;0.7499413753476991;9.223059144383958;66.19362175939281;5.420364800990877;0.0022154409498949313;0.628117073252615;[YY1, DDB1, CREBBP, CDKN1A, HIST3H2A, RHBDD1, TP53INP1, PBK, EP300, PPID, CDC25A]
GO:0035735;intraciliary transport involved in cilium assembly;8.0;1.0;0.875;9.628524252492122;77.80597868627544;6.088194173566533;0.0026040960857949586;0.6863505331661754;[IFT122, TNPO1, WDR34, DYNLL2, CLUAP1]
GO:0032469;endoplasmic reticulum calcium ion homeostasis;10.0;0.8259837884571596;0.8282329060895002;9.52844079393514;288.6919123283276;6.686031174322154;0.009662258499776054;0.7571649570480019;[WFS1, ATP2A2]
GO:0032467;positive regulation of cytokinesis;7.0;0.7043150770688792;0.7030769037916401;9.015419779605713;142.0565341908292;6.193554689224359;0.004754504356786525;0.6676580400938822;[SPAST, NUP62, KIF14, PKP4, KIF23, ECT2, CIT]
GO:0010795;regulation of ubiquinone biosynthetic process;7.0;0.8933024483968273;0.7975705894556142;9.485423408851448;124.09101712913485;9.777073627680469;0.0041532146686472605;0.8509193652572005;[COQ3]
GO:0030049;muscle filament sliding;6.0;1.0;0.8231203125901445;9.628524252492122;20.959081145343944;6.139487467954083;7.014815839862524E-4;0.6370939872166814;[MYL6B]
GO:0006071;glycerol metabolic process;7.0;0.7866048967936545;0.7442218136540277;9.303101852057495;71.14030572701571;6.832634648514029;0.0023810020105647298;0.7003406189322132;[COQ3, TPI1]
GO:0035970;peptidyl-threonine dephosphorylation;8.0;1.0;0.875;9.628524252492122;179.24922260518233;7.004484905440688;0.005999310166768488;0.7332096838060964;[PPP2CA, DUSP5, PPM1G]
GO:0022417;protein maturation by protein folding;6.0;1.0;0.8231203125901445;9.628524252492122;59.34513748383371;7.57984905034425;0.001986228344427665;0.710754145523778;[WFS1]
GO:0046600;negative regulation of centriole replication;11.0;0.9326813400603323;0.8987696223598284;9.590783924509275;466.4695881312043;7.697632086000634;0.015612317319377515;0.8260862151842345;[BRCA1]
GO:2000620;positive regulation of histone H4-K16 acetylation;13.0;1.0;0.9625549647676366;9.628524252492122;1673.9769773112196;9.083926447120524;0.056026502949136;0.9271073857191605;[BRCA1]
GO:0019255;glucose 1-phosphate metabolic process;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;72.82688802824934;9.083926447120524;0.0024374504023614934;0.7547934328124444;[PGM3]
GO:0031122;cytoplasmic microtubule organization;6.0;0.811012628672052;0.7286266269261705;9.260799472366804;50.45034613020222;5.734022359845919;0.0016885276826141221;0.6163584827319739;[SPAST, KIF19, TUBGCP2, CIB1, TUBG1, KPNB1, CLASP1, RAB11A, PAFAH1B1]
GO:0035722;interleukin-12-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.948432231191374;0.00101047745553359;0.6551224661907153;[RAP1B, CFL1, PSME2, IL12A, LCP1]
GO:0031247;actin rod assembly;7.0;1.0;0.8509193652572005;9.628524252492122;41.17892776326213;9.083926447120524;0.0013782216536074466;0.8154717862087246;[HSP90B1]
GO:0007095;mitotic G2 DNA damage checkpoint;11.0;1.0;0.9324289523296623;9.628524252492122;857.7571147403349;6.7325511899570465;0.028708358699073767;0.7767319332797141;[FANCI, TAOK2, DONSON, TOPBP1]
GO:0033260;nuclear DNA replication;10.0;0.8653626801206646;0.8479223519212526;9.551563211355994;268.92620209745564;8.67846133901236;0.009000717966333083;0.8590579283277371;[DONSON]
GO:0007093;mitotic cell cycle checkpoint;7.0;0.7140352122741334;0.7079369713942671;9.0094850440859;132.2042645947957;5.142344639450834;0.0044247577598742595;0.6138991092621975;[FANCI, TIPIN, ZWILCH, INTS3, DONSON, MAD2L1BP, BUB1B, BRCA1, ZWINT, CENPF, TPR, TAOK2, CDK2, ZNF207, KNTC1, TOPBP1, MAD2L1]
GO:0007098;centrosome cycle;4.0;1.0;0.75;9.628524252492122;37.692070457630365;6.088194173566533;0.0012615196775557923;0.5613505331661754;[FES, NUP62, BRCA1, CKAP5]
GO:0007099;centriole replication;6.0;1.0;0.8231203125901445;9.628524252492122;79.09414177220606;6.781341354126479;0.0026472097450095456;0.6699184248047958;[CENPJ, CDK2]
GO:0007096;regulation of exit from mitosis;8.0;0.7763722522362496;0.7631861261181248;9.249034630787218;94.90422389775904;6.8867018697843045;0.0031763589656016605;0.7271862538851576;[MAD2L1BP, KNTC1, SIRT2]
GO:0051928;positive regulation of calcium ion transport;8.0;0.7043150770688792;0.7271575385344395;8.848365694942547;69.31158403183679;5.085725745451326;0.002319796341169766;0.6350842511328143;[PDGFRB, CD4, P2RX4, WFS1, CCL5, CALM3, CALM1, CALM2, NTSR1]
GO:0008064;regulation of actin polymerization or depolymerization;9.0;0.6729672293956388;0.7327242398781084;9.05316010758856;119.88573797499163;4.556717802602145;0.004012467759863614;0.6292713855144111;[VASP, MTPN, NCKAP1, ACTR2, WDR1, WIPF2, ARPC1A, IQGAP2, SSH3, SPTB, CORO1A, CIT, VIL1, ARPC2, CFL1, NCKAP1L, ARFIP1]
GO:0045368;positive regulation of interleukin-13 biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;9.777073627680469;0.027942676825076673;0.875;[IRF4]
GO:0000212;meiotic spindle organization;7.0;0.7671156992804218;0.7344772148974115;9.168991923113682;69.6769368299192;7.292166977892469;0.002332024370525413;0.7238411236270654;[ESPL1, FBXO5, TUBG1]
GO:0002762;negative regulation of myeloid leukocyte differentiation;8.0;0.7671156992804218;0.7585578496402109;9.352270875863963;700.1468303315412;5.948432231191374;0.02343328431995837;0.6792031009335148;[SFRP1, GPR55, LILRB3, C1QC, NME1]
GO:0001666;response to hypoxia;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;21.16160540946;4.1860866471696125;7.082598888462125E-4;0.5043176776701113;[BECN1, ITPR2, RORA, THBS1, TM9SF4, HSP90B1, NPEPPS, ALKBH5, CCNB1, NPPA, LMNA, UBQLN1, EP300, SCAP, ATP7A, CREBBP, EGLN2, ITGA2, ARNT, SIRT2, SFRP1, TBL2, DDIT4, HYOU1, KCNK3]
GO:0045132;meiotic chromosome segregation;4.0;0.7980440201809971;0.6490220100904985;9.089527751759436;42.955130674290615;6.8867018697843045;0.001437669566560732;0.6021862538851576;[ESPL1, NUF2, SMC4, SMC2]
GO:0015949;nucleobase-containing small molecule interconversion;6.0;0.7671156992804218;0.7066781622303554;9.271849308553389;109.52544358977337;6.409777797693995;0.003665718030449963;0.6509166472493662;[TXNRD1, NME1]
GO:2000510;positive regulation of dendritic cell chemotaxis;10.0;0.9326813400603323;0.8815816818910864;9.593432932680852;509.141903474748;7.697632086000634;0.01704052131133542;0.8088982747154926;[C1QBP, IL12A]
GO:0034589;hydroxyproline transport;9.0;1.0;0.896240625180289;9.628524252492122;99.64665819327074;9.777073627680469;0.0033350839735586677;0.896240625180289;[SLC1A4]
GO:0050715;positive regulation of cytokine secretion;9.0;0.6913464685778243;0.7419138594692012;9.0689084645567;549.4808578036607;5.03214149931722;0.0183906298100222;0.6535845754738829;[XBP1, IL4R, CADM1, GLMN, PTPN22, NLRP12, KARS, NLRP7, NLRP3, MBP, CCL19, CD244, HAVCR2]
GO:0015826;threonine transport;10.0;0.9326813400603323;0.8815816818910864;9.55953138100517;85.82177420350179;9.777073627680469;0.0028723775480089153;0.9152410118609203;[SLC1A4]
GO:0015825;L-serine transport;11.0;0.8933024483968273;0.8790801765280758;9.510741216835738;156.85333935075835;7.474488534686424;0.005249740109229274;0.8146746435927894;[SLC1A4, SERINC3]
GO:0050830;defense response to Gram-positive bacterium;7.0;1.0;0.8509193652572005;9.628524252492122;71.44439831434403;5.334422371190153;0.0023911797157970473;0.6237219733958743;[IL6, SEH1L, HIST1H2BJ, PPP1R11, NLRP3, DEFB1, IL12A, RNASE3, HIST1H2BC, HAVCR2]
GO:0035556;intracellular signal transduction;5.0;0.5140152493238541;0.5472486365228473;6.9204740513899115;23.17027026302992;2.4005655013542495;7.75488093814194E-4;0.41300604323788886;[RAB3B, NCKAP1, OXTR, DGKD, DGKA, CD80, SIRPG, IL5RA, DEFB1, IGF1R, RAB43, RPS6KA4, DOCK11, RPS6KA2, ARHGDIB, CFL1, ARL6IP5, EP300, SNIP1, GTSE1, IFNAR2, PDGFRB, IGFBP5, ERN1, BCR, NISCH, DEPDC1B, KARS, DDIT4, ELMO1, KPNB1, DIABLO, CLEC16A, ITPR2, RASGRP2, KRCC1, CRHR1, RASGRP4, STK3, RAP1B, ABR, NUAK1, CCNB1, RHOT2, RHOT1, ZMAT1, RRAS, TBXA2R, STK38, TP53BP2, DVL3, STK38L, MBP, RIPK1, ECT2, RAB6A, MARK2, XBP1, SETDB1, EIF2AK3, IFT122, CNOT10, RAB27B, NFKB1, SETX, NFKBIA, CNOT4, CNOT6, IRAK1BP1, COL1A2, PTPRA, CNOT1, GNAQ, RCAN3, BCL3, CNOT3, CDK2, NMUR1, CALM3, CNOT8, CALM1, RGL1, CALM2, BCAR3, BTG2, CDKN1A, MCTP1, PRKCSH, MAST3, YWHAB, DOCK8, ATP2A2, BRCA1, BBC3, POLB, FLCN, AKAP13, AKAP11, NKIRAS1, C1QBP, CASP2, CTSH, RAB8B, CCR2, DUSP5, KSR1, SPHK1, OXSR1, TMEM173, MASTL, GFRA2, SPTB, SIRT2, VAV1, CIT, ITPKB, GAL, ALS2, TFDP2, TAX1BP3, PIK3C3, LCP2, ARHGEF1, LCP1, DOCK2, ARHGEF5, EXOC1, HBEGF, ROCK2, TANK, RELA, RAB21, PPP2CA, GNG2, RAB20, PABPN1, CCL5, PERP, TIFA, MKNK2, NCAM1, ZNF622, RAB28, BID, E2F7, E2F8, MAP3K3, ARFGEF2, CCL20, TSHR, RAB11A, SNRK, ITCH, P2RX4, TNIP2, CAMK4, RAB13, TAOK2, RAB18, CCM2, KRAS, CAMK1, ASB3]
GO:0033138;positive regulation of peptidyl-serine phosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;778.6672313762616;5.152100814396198;0.026061291479152104;0.6787196871063318;[BCAR3, IL6, CAMK1, GFRA2]
GO:0035672;oligopeptide transmembrane transport;8.0;0.7369933605727446;0.7434966802863723;8.986670366319727;50.32547990123027;8.16763571524637;0.0016843485223027412;0.7926932703116032;[ABCB9]
GO:0033490;cholesterol biosynthetic process via lathosterol;8.0;1.0;0.875;9.628524252492122;431.4567121071901;8.390779266560578;0.014440467868396407;0.8041048419030481;[EBP]
GO:0010032;meiotic chromosome condensation;8.0;1.0;0.875;9.628524252492122;72.23175504670313;8.16763571524637;0.002417531837054052;0.7926932703116032;[SMC4, SMC2]
GO:0098909;regulation of cardiac muscle cell action potential involved in regulation of contraction;6.0;1.0;0.8231203125901445;9.628524252492122;24.09825301254981;7.697632086000634;8.065468413103714E-4;0.7167775754447168;[ATP2A2]
GO:0050728;negative regulation of inflammatory response;7.0;0.6729672293956388;0.6874029799550199;8.712233520617966;126.17514047852296;5.085725745451326;0.004222968401562039;0.6110036163900148;[BCR, ABR, NLRP12, CUEDC2, NLRP7, PBK, NLRP3, RORA, NFKB1, IL22RA2]
GO:0000226;microtubule cytoskeleton organization;5.0;0.579397892394798;0.5799399580583193;7.662411396119289;30.307791186580253;3.8212362582156385;0.0010143744957736317;0.4856592118117268;[SPAG16, HDAC3, TUBGCP2, CIB1, TUBA1C, CCNB1, TUBA1B, SPAST, KIF19, NUF2, LMNA, ZNF207, FBXO5, NEFH, CLASP1, MARK2, BBS2, UBE2B, TUBG1, CKAP5, IQCG, NDC80, RAB11A, NSFL1C, CENPE, NIN, SON, NCOR1, ESPL1, CDK5, FES, KIF4A, CENPJ, TBCE, KIF2C, KIF20A, VAMP4, CALM1, MAPRE1, KPNB1, PAFAH1B1, SPC25]
GO:0033489;cholesterol biosynthetic process via desmosterol;8.0;1.0;0.875;9.628524252492122;431.4567121071901;8.390779266560578;0.014440467868396407;0.8041048419030481;[EBP]
GO:0070317;negative regulation of G0 to G1 transition;7.0;1.0;0.8509193652572005;9.628524252492122;83.03241800612349;6.139487467954083;0.002779020306340262;0.6648930398837374;[RAD51, TFDP2, MAX, CDC7, BRCA1, EZH2]
GO:0010389;regulation of G2/M transition of mitotic cell cycle;8.0;0.7369933605727446;0.7434966802863723;8.986670366319727;58.92720908338202;4.74012102526684;0.001972240656975688;0.6174100096703167;[FANCI, DCTN3, KIF14, DONSON, CDC7, BRCA1, TUBG1, CKAP5, RAB11A, CDC25A, CENPF, GPR132, CCNB1, RAD51C, PKIA, RAD21, CENPJ, CEP70, TAOK2, CDK2, TOPBP1, MAPRE1, CLASP1, PAFAH1B1]
GO:0007076;mitotic chromosome condensation;8.0;0.8933024483968273;0.8216512241984136;9.461470167828956;40.5466901453896;7.004484905440688;0.0013570612295141678;0.7332096838060964;[NIPBL, SMC4, SMC2]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[CDKN1C, BTG2, CDKN1A, CD80, LST1, SIRPG, CIB1, COMT, FLCN, ADORA3, RPS6KA2, FNTB, NUP62, TRIM24, CTLA4, IL12A, RBM5, HAVCR2, KLF13, IGFBP5, ATPIF1, EMP3, PDCD1LG2, SIRT2, NME1, SFRP1, TWSG1, GAL, KARS, TAX1BP3, BECN1, THBS1, STK3, TP53INP1, LMNA, CSK, E2F7, TFAP2A, ZBTB17, CDKN2C, IDH2, GLMN, EAF2, IFT122, PER2, ITCH, IL6, FAP, NFIB, CD9, MNDA, CNOT8, TRIM32]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[CDKN1A, WDR48, TFRC, ITGB3, CD80, SIRPG, CCNF, KIF14, CIB1, IGF1R, TIAL1, PPP1CC, LBH, FNTB, CTSH, SOX8, IL12A, ATP7A, SKP2, CCR2, HLA-DPA1, HAVCR2, PDGFRB, RPS9, TIPIN, CSNK2A1, IGFBP5, SPHK2, ITGA2, SPHK1, TBC1D8, ARNT, FLT3LG, PDCD1LG2, RUNX2, NME1, ERN1, SFRP1, CCNE2, IL23A, CCNE1, EPHA1, HBEGF, HDAC1, FOXG1, EBI3, DERL2, CRIP2, THBS1, CORO1A, RELA, CCNB1, HLA-DMB, CCL5, NCKAP1L, CCL19, TBX1, MAP3K3, XBP1, CDC7, TSHR, CNOT6, CD4, IL6, SP1, CDK2, HLA-DPB1, KRAS, FAM98A, CNOT8, CCNJL]
GO:0046599;regulation of centriole replication;10.0;0.8259837884571596;0.8282329060895002;9.503361109538115;89.11396308082499;6.943860283624253;0.002982564146955293;0.7703503496879909;[CENPJ, NUP62, BRCA1]
GO:1902857;positive regulation of non-motile cilium assembly;10.0;1.0;0.9152410118609203;9.628524252492122;454.9540798663577;7.697632086000634;0.015226903621037693;0.8088982747154926;[CENPJ]
GO:0002860;positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target;10.0;1.0;0.9152410118609203;9.628524252492122;1230.3276479854385;7.8311634786251565;0.041177959155076445;0.8157270763441555;[IL12A]
GO:2000778;positive regulation of interleukin-6 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;618.0674169630446;6.599019797332524;0.02068616022119099;0.7527151911823093;[XBP1, MBP]
GO:0015808;L-alanine transport;11.0;0.8933024483968273;0.8790801765280758;9.567899630675686;156.4478742426539;7.8311634786251565;0.005236169556955925;0.8329150168128974;[SLC36A1, SLC1A4]
GO:0048662;negative regulation of smooth muscle cell proliferation;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;63.58586787906956;5.970411137910149;0.0021281617743466354;0.6284474158353811;[CDKN1A, IGFBP5, IL12A, COMT]
GO:0001649;osteoblast differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;5.171903441692378;7.050676185779127E-4;0.5144913825262545;[RPS15, SFRP1, IGFBP5, TP53INP2, H3F3A, HSD17B4, SOX8, RRBP1, HSPE1, SND1, RUNX2]
GO:0036500;ATF6-mediated unfolded protein response;6.0;1.0;0.8231203125901445;9.628524252492122;80.02054155744251;7.57984905034425;0.0026782155121157316;0.710754145523778;[XBP1, HSP90B1]
GO:0071318;cellular response to ATP;7.0;1.0;0.8509193652572005;9.628524252492122;523.2473722673394;7.212124270218933;0.01751261865772571;0.7197477358342742;[P2RX4, HSP90B1]
GO:0060770;negative regulation of epithelial cell proliferation involved in prostate gland development;7.0;1.0;0.8509193652572005;9.628524252492122;209.0820823569653;7.9853141584524145;0.006997789134829996;0.7592887026755414;[EAF2]
GO:0007088;regulation of mitotic nuclear division;7.0;0.5860072649471136;0.6439229977307573;8.169909229792605;54.97351338155213;4.573066940603674;0.0018399140199305624;0.5847862212690335;[BECN1, CCNF, BUB1B, PKMYT1, ANAPC11, NIPBL, CCNB1, CDC26, RAD21, TPR, NUP62, ZNF207, KNTC1, FBXO5, PDGFRB, NSMCE2, MAD2L1BP, NDC80, SIRT2, NSFL1C, CENPE, CENPF, STAG1, STAG2, ESPL1, CCNE2, CCNE1, CHMP4B, ANAPC5, CCNJL, MAD2L1]
GO:0055089;fatty acid homeostasis;7.0;1.0;0.8509193652572005;9.628524252492122;32.348635705990986;7.138016298065211;0.0010826797251974863;0.7159578506919597;[XBP1]
GO:0008295;spermidine biosynthetic process;9.0;1.0;0.896240625180289;9.628524252492122;340.8203908116312;8.67846133901236;0.011406951762027414;0.8400575416471059;[AMD1, AGMAT, SRM]
GO:0048666;neuron development;4.0;0.6696747006330769;0.5848373503165385;8.088079211544972;32.15320660831846;4.814228997420562;0.001076138889173156;0.4961998948126311;[BECN1, BTG2, XBP1, ONECUT2, PBX3, THOC2, MYO7A, GBA2, FXR1, GNAT2, CDK5, UQCRQ, GNAQ, ATP7A, PAFAH1B1]
GO:0061502;early endosome to recycling endosome transport;6.0;1.0;0.8231203125901445;9.628524252492122;50.18376484494501;9.083926447120524;0.001679605446904144;0.7876727335416686;[MYO1D, CORO1A]
GO:1903827;regulation of cellular protein localization;5.0;0.4816167172285496;0.5310493704751951;6.85593553025234;25.722958397114;3.605373030269554;8.609242683918189E-4;0.47461995629589737;[USP36, CDKN1A, YWHAB, ITGB2, OTUD7B, CIB1, ABCA12, BBC3, UBE2L3, NPEPPS, FLCN, UBL5, NIPBL, NUP62, PPFIA1, GTSE1, FCER1G, DTX3L, ATPIF1, THOC2, TMEM173, YWHAZ, TFDP2, CCNE2, CCNE1, RUFY3, TAX1BP3, LCP1, HDAC3, EPB41, ROCK2, DERL3, DERL2, SUPT6H, PARL, TM9SF4, BAG3, TP53INP2, TPR, LMNA, VPS11, TP53BP2, DVL3, CSK, LRIG2, ECT2, BID, TMEM30A, TOR1A, EDEM1, EIF2AK3, NDC80, RAB11A, VIL1, NSFL1C, GNL3L, CDK5, PKIA, CAMK1]
GO:1990830;cellular response to leukemia inhibitory factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.266214121163619;0.0027327542132076126;0.5924347476504533;[TLE4, BCLAF1, XBP1, TFRC, PMM1, XRCC5, MTF2, ADAM23, NEFH, BSPRY, SRM]
GO:0032496;response to lipopolysaccharide;5.0;0.8933024483968273;0.736892236059334;9.446202695698167;64.414971589946;4.086714173356409;0.002155911129404774;0.4992357647380114;[UPF1, XBP1, ABCC2, CCL20, GFI1, CD80, ATP2A2, TNFRSF10A, PTPN22, PDCD1LG2, COMT, NFKB1, RELA, BCR, ABR, IL6, PABPN1, NLRP7, TBXA2R, TNIP2, NLRP3, IL12A, HAVCR2]
GO:0032012;regulation of ARF protein signal transduction;9.0;0.8933024483968273;0.8428918493787028;9.461470167828956;48.758993290020136;6.943860283624253;0.0016319196251719597;0.7513499630073597;[ARFGEF2, PSD4]
GO:0015811;L-cystine transport;10.0;0.9326813400603323;0.8815816818910864;9.571365838652174;254.95955250308688;8.390779266560578;0.008533266773578137;0.8443458537639685;[CTNS, SLC1A4]
GO:0035524;proline transmembrane transport;11.0;0.8653626801206646;0.8651102923899945;9.584072489921288;330.9290371701472;7.9853141584524145;0.011075897057287277;0.8407982897480031;[SLC36A1, SLC1A4]
GO:0034393;positive regulation of smooth muscle cell apoptotic process;9.0;0.9326813400603323;0.8625812952104552;9.56398573135455;127.00837127343294;7.212124270218933;0.004250855886408647;0.7650689957573628;[IL12A]
GO:0042176;regulation of protein catabolic process;6.0;0.5945822691631375;0.6204114471717133;8.214830917184116;56.791667214012804;3.8826707934156186;0.001900765992470805;0.5216802775280761;[ZFAND2A, DERL3, CLEC16A, DERL2, RELA, ARNTL, GGA3, PSMD2, VPS11, UBQLN1, PBK, STX5, LRIG2, NUDT15, FAM83D, DACT1, XBP1, EGLN2, CSNK2A1, RPS7, EDEM1, ATPIF1, GLMN, RAD23A, SIRT2, DDB1, ITCH, PSMC1, PSME2, TRIM32, MAD2L1]
GO:0060968;regulation of gene silencing;6.0;0.6181399273706679;0.6321902762754785;8.242229891372231;28.71512877910424;5.407625775213448;9.610695182985184E-4;0.599666546214876;[FXR1, IPO8, NCOR1, SETDB1, POLR2B, H3F3A, ATAD2, CDK2, POLR2G]
GO:0043388;positive regulation of DNA binding;5.0;0.7090535922965819;0.6447678080092112;8.578702127993445;32.525455185636034;5.825829909099042;0.0010885977140540058;0.5881742243410422;[NIPBL, IRF4, ITGA2, PLAUR, SIRT2, NME1]
GO:0000022;mitotic spindle elongation;4.0;1.0;0.75;9.628524252492122;36.9885698197415;9.083926447120524;0.001237974144315121;0.714552420951524;[KIF23]
GO:0006914;autophagy;4.0;0.6729672293956388;0.5864836146978194;8.39638057119949;37.75222312160081;4.39717627414001;0.001263532933085;0.4748717991491287;[BECN1, CALCOCO2, ITGB4, CLEC16A, PTPN22, FNBP1L, CLN3, LAMP2, VPS11, UBQLN1, C6orf106, MARK2, VPS18, GABARAPL1, XBP1, VTA1, PGA3, DYNLL2, PRKAB1, PGA5, SIRT2, VPS41, CHMP4B, PIK3C3, CHMP6]
GO:2000675;negative regulation of type B pancreatic cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;129.9263443150347;7.9853141584524145;0.0043485178181058145;0.8046099625986299;[WFS1]
GO:0071732;cellular response to nitric oxide;6.0;1.0;0.8231203125901445;9.628524252492122;346.50110413771324;7.004484905440688;0.011597080124741305;0.6813299963962409;[CDK2]
GO:0035356;cellular triglyceride homeostasis;8.0;1.0;0.875;9.628524252492122;50.566380672597894;7.8311634786251565;0.001692411254323797;0.7754860644832351;[XBP1]
GO:0014898;cardiac muscle hypertrophy in response to stress;7.0;1.0;0.8509193652572005;9.628524252492122;75.67165931027915;7.138016298065211;0.002532662337043095;0.7159578506919597;[NPPA, ATP2A2, EZH2]
GO:0035470;positive regulation of vascular wound healing;8.0;1.0;0.875;9.628524252492122;265.3071812688393;9.083926447120524;0.008879592596106585;0.839552420951524;[XBP1]
GO:0045454;cell redox homeostasis;5.0;1.0;0.7902410118609202;9.628524252492122;31.944097044200298;5.572381008289503;0.0010691401802485107;0.5752128357670632;[EGLN2, TXNRD1, PRDX1, TXNDC11]
GO:0046785;microtubule polymerization;7.0;1.0;0.8509193652572005;9.628524252492122;97.26999823215544;7.292166977892469;0.0032555393035152377;0.7238411236270654;[CENPJ, ZNF207, FBXO5, CKAP5]
GO:0000028;ribosomal small subunit assembly;7.0;1.0;0.8509193652572005;9.628524252492122;66.59596265062147;6.832634648514029;0.002228906937441061;0.7003406189322132;[RPS15]
GO:0045582;positive regulation of T cell differentiation;9.0;0.7043150770688792;0.7483981637147287;9.320222892837606;861.1600055729926;5.395046993006588;0.0288222503928399;0.6721435792979885;[ITPKB, XBP1, IL4R, IL23A, CD80, NLRP3, NCKAP1L, IL12A, CCL19]
GO:0070512;positive regulation of histone H4-K20 methylation;11.0;1.0;0.9324289523296623;9.628524252492122;803.63682017253;9.777073627680469;0.02689700114499224;0.9324289523296623;[BRCA1]
GO:0070757;interleukin-35-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;7.379178354882098;0.00101047745553359;0.728290889492758;[EBI3, IL12A]
GO:0014883;transition between fast and slow fiber;8.0;1.0;0.875;9.628524252492122;30.57164975977287;7.8311634786251565;0.0010232056047610899;0.7754860644832351;[ATP2A2]
GO:0008089;anterograde axonal transport;9.0;0.8259837884571596;0.8092325194088689;9.405380701177911;71.1020239957658;6.113511981550823;0.0023797207554711163;0.7088859122241795;[RAB21, FXR1, AP3M1, SPAST, KIF4A, TRAK1]
GO:0009298;GDP-mannose biosynthetic process;8.0;0.8933024483968273;0.8216512241984136;9.557065288509976;615.242755880766;8.390779266560578;0.02059162135679706;0.8041048419030481;[GMPPB, PMM1]
GO:0045348;positive regulation of MHC class II biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;147.28763043943843;7.9853141584524145;0.0049295844405465;0.7592887026755414;[CIITA, XBP1]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[CIITA, BTG2, GFI1, OTUD7B, IKZF2, YY1, FLCN, NIPBL, C1QBP, SAP130, WWC3, EP300, SOX8, LRRFIP1, HIF1AN, CIC, ZNF564, DACT1, TLE4, KLF12, PEG3, ZBTB32, ARID1A, SIRT2, DUSP22, EID1, BRMS1, NCOR1, TBL1XR1, CCNE1, MTF2, HOXB4, TIMELESS, LCOR, PPID, HDAC3, ZNF350, HDAC1, MAX, FOXG1, LRP8, RELA, MTDH, RXRA, BAG3, TPR, HIVEP1, HESX1, SUDS3, MTA2, E2F7, ZNF189, E2F8, IRX1, TFAP2A, DR1, CREBBP, UBE2I, WFS1, NFKB1, PER2, GFI1B, CNOT1, NFIB, NFIC, PKIA, SP3, CDK2, NFE2L3, TAF7, EZH2]
GO:0045471;response to ethanol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;69.73224034292265;5.006389003214805;0.0023338753293357085;0.5462679783062231;[POLB, EEF1B2, ACTR2, SETDB1, TBXA2R, TP53INP1, ITPR2, SDF4]
GO:1902808;positive regulation of cell cycle G1/S phase transition;8.0;0.8933024483968273;0.8216512241984136;9.5544162803384;106.07932343249502;6.113511981550823;0.003550379490092644;0.6876452870438905;[ANKRD17, FAM83D]
GO:0035335;peptidyl-tyrosine dephosphorylation;8.0;0.8933024483968273;0.8216512241984136;9.52844079393514;179.24922260518233;5.181953777545879;0.005999310166768488;0.6400053571691908;[PTP4A1, DUSP22, DUSP23, DUSP5, PTPRA, EYA2, DUSP28, PTPN22, SSH3, CDC25A, DUSP14]
GO:0035690;cellular response to drug;4.0;0.5629771490299041;0.531488574514952;7.020557509946895;41.90713853914268;4.145861845859104;0.0014025942129290189;0.462019567599527;[BECN1, ERRFI1, TFRC, ITPR2, PTPN22, BRCA1, RELA, HSP90B1, EFTUD2, RAP1B, TP53INP1, ECT2, ABCC2, CAD, NFKB1, NME1, SETX, SFRP1, IL6, RAD51, P2RX4, XRN1, DDIT4, CDK2, TIMELESS, EZH2]
GO:0034122;negative regulation of toll-like receptor signaling pathway;8.0;0.7140352122741334;0.7320176061370667;9.0094850440859;260.8137256220838;6.166155715036245;0.00872920067945721;0.6903374900225189;[IRF4, UBQLN1, LILRA2]
GO:0044030;regulation of DNA methylation;7.0;0.7980440201809971;0.7499413753476991;9.253830803050711;73.34977914704017;6.7325511899570465;0.0024549510975359675;0.6952223462072524;[BRCA1, RLF]
GO:0099178;regulation of retrograde trans-synaptic signaling by endocanabinoid;6.0;1.0;0.8231203125901445;9.628524252492122;27.32355736088522;9.777073627680469;9.144948752636959E-4;0.8231203125901445;[FABP5]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[AVEN, BTG2, CDKN1A, DOCK8, KIF14, CIB1, BRCA1, AATF, UBE2Z, IGF1R, NUP62, CFL1, CASP2, CTSH, SOX8, IER3, PDGFRB, TSC22D4, FGA, DFFA, FCER1G, CSNK2A1, SPHK2, SPHK1, FGG, PLAUR, FLT3LG, YWHAZ, DDB1, ITPKB, CREB3, SFRP1, CFDP1, PTRH2, VDAC2, ADNP, EPHA1, PPID, BECN1, HDAC3, HDAC1, NLRC4, THBS1, CORO1A, RELA, MTDH, HSP90B1, CLN3, BAG3, CCL5, LMNA, NCKAP1L, RIPK1, CCL19, RFFL, SNCB, BID, NTSR1, TBX1, TFAP2A, PRELID1, XBP1, UBE2B, EYA2, WFS1, NONO, RHBDD1, SYVN1, TNFRSF10A, NFKB1, SETX, VIL1, NFKBIA, ITCH, IL6, SON, COPS5, TNIP2, BCL3, KRAS, ERCC5, HYOU1, PDCD1, TRIM32, MAD2L1, CPEB4]
GO:0034599;cellular response to oxidative stress;4.0;0.7248374789738407;0.6124187394869203;8.935377071932177;68.67201153720991;4.519578255652688;0.0022983904253524798;0.48113144217596127;[BECN1, NCF1, TXNRD1, GPX7, ATP2A2, VRK2, SIRT2, RELA, SETX, IL6, CCS, PRDX1, TP53INP1, PXMP2, CDK2, ECT2, NFE2L1, EZH2]
GO:0033147;negative regulation of intracellular estrogen receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;234.23542340630428;7.138016298065211;0.007839648823214116;0.7400384854347593;[LBH, CNOT1, CRIPAK, BRCA1]
GO:0032298;positive regulation of DNA-dependent DNA replication initiation;10.0;0.8933024483968273;0.861892236059334;9.566003895510788;1058.995272857269;9.777073627680469;0.03544361874866342;0.9152410118609203;[CDK2]
GO:2000347;positive regulation of hepatocyte proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;189.09591637334557;7.8311634786251565;0.0063288701457398545;0.7514054297404357;[XBP1]
